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                           INTRODUCTION 
                      
                   Helicobacter pylori (H. pylori) is one  of  the most common infectious agent 
found in  gastrointestinal tract worldwide (1). H. pylori was discovered by Barry Marshall and 
Robin Warren in 1982. They were awarded Nobel prize in Physiology and Medicine in 2005 
for their important discovery that this bacterium was the responsible agent for chronic peptic 
ulcer. H. pylori has got a special tropism for gastric mucosa and is responsible for a variety of 
gastric diseases ranging from peptic ulcer to gastric adenoma and lymphoma.   
                    Recently, Helicobacter pylori has been associated with numerous extra gastric 
diseases as well. It has been linked to diseases involving cardiovascular, hepatobiliary, 
dermatological, immunological and haematological systems. The organism  has been 
demonstrated in patients with ischemic heart disease, idiopathic thrombocytopenic purpura, 
iron deficiency anaemia, colorectal cancers etc (1). H. pylori has been detected in saliva, dental 
plaques and palatine tonsils by polymerase chain reactions. The infection is acquired by oral 
route (2).   
                        Studies have detected the presence of H. pylori in the oral cavity of patients with 
dyspeptic symptoms (3). Larynx is a region that could be directly exposed to the bacterium by 
means of laryngopharyngeal reflux. Laryngopharyngeal reflux presents in a variety of 
manifestations like globus sensation, hoarseness, dysphagia, sore throat, postnasal drip, chronic 
cough, frequent throat clearing, voice fatigue etc. This has been also associated with multiple 
laryngeal pathologies like vocal granuloma, polyps, nodules, Reinke’s oedema etc. Whether 
the bacteria reaches the larynx from the stomach by reflux or it reaches directly from the oral  
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cavity are controversial issues. There are conflicting studies regarding the presence of H. pylori 
in larynx.  
                        Some studies have shown a positive association between H. pylori and laryngeal 
disorders whereas some do not support this. In 2011 Pajić-Penavić et al (4)  conducted PCR 
analysis on cytobrush samples obtained from normal laryngeal mucosa and concluded   that H. 
pylori was  not present  in normal laryngeal  mucosa. Previous studies conducted in this field 
to establish a link between H. pylori and laryngeal disorders have yielded conflicting results. 
The goal of our study was to find the prevalence of H. pylori in patients with laryngeal 
pathologies and the significance of laryngopharyngeal reflux in these patients. 
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AIM 
 To study the prevalence of Helicobacter pylori in patients with laryngeal pathologies. 
 
 OBJECTIVE  
Primary objective 
To study the infection rate of Helicobacter pylori in patients with laryngeal pathologies. 
 
 
Secondary objective 
1) To study the association of laryngopharyngeal reflux in patients with laryngeal   pathologies 
by means of Reflux Symptom Index and Reflux Finding Score. 
2) To study the association of laryngopharyngeal reflux in patients whose biopsies are positive 
for H. pylori.  
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                      REVIEW OF LITERATURE 
 
                           Helicobacter pylori infection has been reported throughout the world and is 
responsible for producing chronic bacterial infection in humans. The prevalence of  H. pylori  
largely depends on the standard of living in the region (5). About 50% of global population is 
thought to be colonised with H. pylori and the infection is mostly acquired within 5 years of 
age. The prevalence varies according to the age, geographic location and the socioeconomic 
status. The prevalence is much higher in developing countries and this can be attributed to  the  
poor  hygiene and overcrowding in these region (6). The prevalence also increases with age  
and is therefore  responsible for development of chronic mucosal inflammation (4). This  
bacterium has got a high tropism for  the  acidic environment  in  the  stomach  and colonizes 
the mucosa of the stomach . Once acquired, the infection persists lifelong. Recently the 
prevalence of H. pylori in extra gastric tissues is widely being studied.  Fellman et al (7) studied 
the prevalence of H. pylori in the upper aerodigestive tract in patients with proven gastric 
colonisation and concluded that the bacterium was found in 38% of samples obtained from oral 
cavity, larynx and pharynx.  
                  Helicobacter pylori  is  a gram negative  micro aerophilic spiral  or helical 
shaped  bacteria  colonizing  human  gastric  epithelial cells. This bacterium has a tuft of 
sheathed unipolar flagella which distinguishes it from campylobacters which has got 
unsheathed flagella. The acidic pH in the stomach is not favourable for its growth and hence 
they penetrate into the mucous layer of stomach which is resistant to the penetration of acid. 
The normal gastric pH is about 1-2 whereas it is about 7.4 inside the mucous layer. Optimal 
growth of Helicobacter pylori occurs in presence of 5-10% oxygen. Optimal temperature for 
its growth is 350 C to 370C (8). 
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                        The gastric antrum is the most favoured site for colonisation by the bacterium. 
They do not invade the gastric mucosa but are found in the mucus overlying the gastric mucosa. 
Gastric acid is  potentially  destructive to the bacteria  but  protection is  provided  by the  urease  
generated  by  them, which converts  urea  to ammonia  thereby  neutralising the  acid  and  
creating  an environment  favourable  to the bacteria (9).  
                     
 H. pylori Secretome. 
                     
                       The proteins that are secreted by the bacterium are generally grouped under    the 
name “secretome”. These proteins play a very important role in pathogenesis, as secreted 
proteins or those that are present on the external surface of the bacterium are responsible for 
all the interactions with host.  H. pylori genome is very small consisting of less than 1600 
genes. The bacterium uses a set of secreted and translocated proteins by which it adapts itself 
to the mucosal environment. The proteins secreted by the bacteria are grouped into different 
classes namely enzymes, outer membrane proteins, flagellar proteins, binding and transport 
proteins. Out of the secreted proteins, cytotoxic- associated genes  pathogenicity island ( cag –
PAI) plays a very important  role in  H. pylori virulence (10). 
                      
                        The cag-PAI is a genomic insert of 27-28 genes. These are present in all type 1   
strains of H. pylori and are absent in type 2 strains. The cag-PAI encodes an effector protein, 
Cag A. The proteins coded by cag-PAI are labelled by the suffix Cag. They are named as Cag 
A, CagB… CagZ, Cagα, etc., or by a number from 1-28. The cag-PAI induces the production 
of Interleukin 8 (IL-8) by the host which is responsible for triggering inflammatory responses 
(11). The Vacuolating cytotoxin A, VacA (HP0289) protein is one another major exotoxin 
secreted by H. pylori. This protein has got cytotoxic property by inducing the formation of 
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intracellular vacuoles thereby producing osmotic swelling of the endocytic compartment and 
are generally known as pore forming toxins (12). Genes encoding for Cag A and Vac A are 
present only in type 1 strains of H. pylori and hence they are responsible for more severe 
disease. The bacteria also secretes a variety of enzymes with antioxidant properties like 
superoxide dismutase (SOD), catalase, thioredoxins  and  peroxiredoxins, NADPH quinone 
reductase, and others like proteases, urease etc. Urease enzyme is made up of two subunits 
namely UreA and UreB. This enzyme has got buffering activity and acts by splitting urea into 
ammonia and carbon dioxide thereby neutralising the acid.       
 
   
 
Fig .1  Helicobacter pylori 
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                   Helicobacter pylori is associated with various pathologies like peptic ulcer, 
non-ulcer dyspepsia and gastric cancer and causes chronic bacterial infections in humans. In 
human stomach H. pylori produces antral predominant gastritis which is linked to duodenal 
ulceration. This bacterium is also considered as a risk factor for Mucosa Associated Lymphoid 
Tissue (MALT) lymphoma. 
                  Earlier human stomach was considered as the only reservoir for this bacterium. 
However  recent  studies  have shown  that  they can also exist  in extragastric  tissues  like 
gingiva, human dental plaque, saliva, laryngeal and pharyngeal tissues (1). In a study  
conducted  by  Fang et al (13) in patients with  hoarseness,  H. pylori colonisation was  found 
in 13 out of 53 patients with vocal cord polyps by means of Rapid urease testing. Wang et al 
(14) reported H. pylori to be present in the dental plaques and that dental biofilms provided a 
microaerophilic environment and urea required for the survival of the bacteria. 
 
Clinical spectrum of H. pylori infection 
 
                     H. pylori infection is considered as the main cause of chronic gastritis, peptic 
ulcer disease and gastric cancer including MALT lymphoma. The bacterial colonisation is 
usually acquired in childhood and the disease manifestation occurs commonly in adults. Not 
all of them who are infected manifest the disease and is dependent on the bacterial, host and 
environmental risk factors. Once H. pylori colonises gastric mucosa it induces histologic 
gastritis with neutrophilic and mononuclear infiltration both in the antrum and corpus of human 
stomach. However, only a few individuals manifest clinical signs of colonisation in the form 
of acute gastritis or chronic gastritis or atrophic gastritis with intestinal metaplasia. The life 
time risk for peptic ulcer disease in H. pylori positive individuals is 3-10 times higher than 
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those who are H. pylori negative. H. pylori is also found to be responsible for non ulcer 
dyspepsia or functional dyspepsia (15).  
                   The International Agency for Research on Cancer, a branch of WHO has 
classified H. pylori as a class 1 carcinogen. It has been recognised as a predisposing agent for 
gastric cancer and gastric marginal zone lymphoma. The most important factor in 
carcinogenesis is the induction of chronic inflammation by H. pylori, there by producing 
oxygen free radicals leading to DNA damage. The host’s immune system plays a critical role 
in the initiation and progression of infection. The neutrophil activating protein of H. pylori 
stimulates production of IL-12 and IL-23 from neutrophils and macrophages by polarizing T- 
helper 1 cells (Th 1). Also Th1 cytokines like gamma interferon (IFN- γ) and tumour necrosis 
factor alpha (TNF- α) increases the release of pro inflammatory cytokines and augment the 
apoptosis caused by H. pylori (16). 
               Association between gastroesophageal reflux disease and Helicobacter pylori 
positivity have yielded conflicting results. Gastroesophageal reflux disease and its 
complications like Barrett’s oesophagus and oesophageal cancer has shown an inverse 
relationship with H. pylori according to some studies. Most studies have shown a probable 
protective role of H. pylori against GERD. Physiology  of  gastric acid  production  depends 
on the gastric location of the bacteria (17). Infection of the gastric corpus by the bacteria causes 
atrophy of the gastric parietal cells which are responsible for acid production, resulting in 
hypochlorhydria and decrease of reflux. Infection of gastric antrum leads to destruction of 
somatostatin secreting cells present in the gastric antrum. Somatostatin secreted by the D cells 
of the gastric antrum plays a negative feedback in acid production. Studies  have  shown that   
destruction of these  cells  leads  to increase  acid  production  and there by  increased   reflux 
(18).  Polat et al (19) studied the severity of GERD and H. pylori positivity  in patients with 
GERD and concluded that the bacterium was present in 82.5% of patients with GERD.  
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Detection of H. pylori. 
 
                    There are   different methods to detect Helicobacter pylori. It can be diagnosed 
by invasive and non invasive methods. Non invasive tests include Urea breath test, serology 
and whole blood antibody tests whereas invasive tests involves taking tissue endoscopically 
for biopsy and further studies. 
 
Urea Breath test (Carbon isotope Urea Breath Test) 
                 The patient should be advised not to take any antibiotics, bismuth containing 
medications or proton pump inhibitors up to two weeks prior to the test. The patient is asked 
to swallow a compound containing urea labelled with 13C. In the presence of H. pylori, the 
urea is converted by the urease present in the bacterium into carbon dioxide which is traced 
in the exhaled air after 10 minutes. This test can also be used after treatment to confirm that 
all  H. pylori  has  been  eradicated (20). 
 
Blood tests  
               These tests measures H. pylori IgG and H. pylori cagA IgG antibodies in the 
blood. If the test is positive, it indicates that the patient was infected by the organism but does 
not tell that the infection is acute or chronic. The test can remain positive for several years 
even after the infection is treated and patient is cured. 
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Biopsy  
                
           The most accurate method of detecting H. pylori is by studying a tissue sample 
obtained by biopsy. Various tests can be done on the biopsied sample to detect the bacterium. 
These include Rapid urease testing, Giemsa staining, immunohistochemical staining, culture, 
and Polymerase Chain Reaction. H. pylori is said to have the maximum urease activity of 
any bacterium known to infect man (21).  
                  In rapid urease testing (RUT), one or two pieces of tissue are placed in an agar 
well containing urea and a pH reagent. Urease present in the bacterium cleaves urea to 
liberate ammonia resulting in an alkaline pH change and a subsequent colour change. The 
urease tests  will give  false  negative  results  in subjects who have been  on proton pump 
inhibitors, H2 receptor antagonists, antibiotics  and  also in  patients  with recent history  of 
gastrointestinal  bleed. The presence of other urease producing organisms will give false 
positive results. Sensitivity of RUT ranges 80% to 90% depending on the test used and the 
condition under which the test was performed.  
                     The histopathological diagnosis of H. pylori is widely employed in gastric 
biopsy specimens. Presence of features of chronic inflammation in the histology is the 
hallmark of active H. pylori infection (22). Stains used in the diagnosis include modified 
Giemsa, Warthin-Starry stain, Gimenez, Genta and immunohistochemical stains.  The 
sensitivity with routine haematoxylin eosin staining is low especially when there are not 
many bacteria. With giemsa staining H. pylori appears as a blue or grey rod like structure in 
a pink or pale blue background with a blue nuclei. Giemsa staining is sensitive, cheap, easy 
to perform, and reproducible. One of the disadvantages of Giemsa staining is that there is  
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little contrast between the organism and the surrounding tissue. Immunohistochemical 
staining techniques overcomes this. Immunohistochemical  stain is considered to be the gold 
standard in histological diagnosis, as  this a highly sensitive and specific test (23).  
 
 
 
 
 
                         Fig. 2  Haemotoxylin and Eosin staining for H. pylori in stomach 
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                                 Fig. 3 Giemsa staining for H. pylori in the stomach 
                   
               Studies have shown that Polymerase Chain Reaction (PCR) is the best method 
for detection of H. pylori and could detect bacteria in those samples which other methods 
could not detect. In PCR, specific sequences within a DNA can be identified  which are  
amplified to many  thousand  to million folds  using sequence  specific  oligonucleotides, 
heat stable DNA polymerase and  thermal  cycling.  
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                In PCR, a special DNA polymerase obtained from Thermophilus aquaticus (Taq 
polymerase) is used to make many copies of a short length of DNA. The PCR amplifies DNA 
exponentially doubling the number of target molecules with each amplification. By using PCR, 
genes from pathogens can be identified and amplified.  Good primer design is one of the most 
important parameters in real time PCR. Primers should be 18-24 nucleotides in length. Real 
time PCR differs from traditional  PCR in  that  amplified  product  is measured  at the end of  
each  cycle (24). Real time PCR has got many advantages over conventional PCR such as high 
specificity, short work time and low risk of contamination. 
 
              In a study conducted by Titiz et al (25) , PCR testing was done for detection of 
H. pylori in patients with laryngeal pathologies. The  PCR  results  of 17  out of 21 samples of 
patients  with  laryngeal  squamous cell  carcinoma was  positive  for H. pylori  and no genomic  
material  of H. pylori was found in patients with benign laryngeal pathologies. In one other 
study conducted by Ozyurt et al (26) Helicobacter pylori virulence factor cag A was detected 
in 17 out of 29 cases of laryngeal biopsy specimen which included both benign and malignant 
lesions  by PCR analysis.  
 
Treatment of H. pylori infection. 
                        H. pylori infection is very common in general population, but it is not 
necessary that all of them who are infected needs to be treated (21). Treatment is indicated 
for patients with peptic ulcer disease or with gastric MALT lymphoma. Combination drug 
regimens maximizes the chance of eradication and minimize the development of drug 
resistance. The most widely accepted regimen in the past was the standard triple therapy 
which included a proton pump inhibitor (PPI), clarithromycin, and amoxicillin or 
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metronidazole for a period of at least 7 days. But clarithromycin resistance became one of 
the major reasons for failure of eradication of H. pylori.    
                        Newer regimens like sequential therapy, concomitant therapy and hybrid 
therapy came into picture to overcome this. Sequential therapy is basically a dual regimen 
and consisted of a five day course of PPI with amoxicillin followed by a five day course of 
PPI with two other antibiotics, usually clarithromycin and metronidazole. Sequential therapy 
was formulated in the year 2000 in response to failure of triple therapy, but eventually both 
clarithromycin and metronidazole resistant strains evolved.  
                      In concomitant therapy, the standard triple therapy is converted to quadruple 
therapy by addition of 500 mg of metronidazole or tinidazole twice daily. The drugs are given 
for a short duration of 5 days. This, one PPI and three antibiotic regimen showed more 
success rates than the previous regimens (27). For patients with failure of concomitant 
regimen, H. pylori rescue regimen with levofloxacin was employed and has shown promising 
results. This consists of triple therapy with PPI, levofloxacin and amoxicillin for a period of 
10 days (28). 
 
ANATOMY OF LARYNX   
             Larynx is a dynamic organ that is responsible for maintaining several 
functions like respiration, swallowing and phonation. Larynx is made up of four anatomic 
units: laryngeal framework, mucosa, intrinsic and extrinsic muscles. A supporting skeleton 
made up of cartilages and intervening membranes is responsible for maintaining its shape. 
Larynx extends from the laryngeal inlet to the inferior border of the cricoid cartilage. The 
laryngeal framework is made up of three unpaired cartilages namely epiglottis, thyroid and 
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cricoid and three paired cartilages namely arytenoid, corniculate and cuneiform cartilages 
(29). 
 
Epiglottis  
             Epiglottis is a flexible, leaf shaped form of elastic cartilage which forms part 
of laryngeal inlet. Inferiorly epiglottis tapers to a point called petiole which is attached to the 
thyroid cartilage just above the anterior commissure. The hyoid bone divides the epiglottis 
into suprahyoid and infrahyoid portions. The suprahyoid portion projects behind the base of 
tongue and thereby protects the larynx during swallowing (30). 
 
Thyroid cartilage 
              Thyroid cartilage is composed of two laminae which are fused in midline and 
spans the entire length of true and false vocal folds. They form a variable angle approximately 
75 to 90 degrees in adult male and 90 to 110 degrees in adult female. The thyrohyoid ligament 
attaches to the superior border of the lamina and the cricothyroid ligament attaches to the 
inferior border on the medial aspect. The two laminae fuse in the midline anteriorly to form 
the laryngeal prominence. The thyroid cartilage is lined by a thick layer of perichondrium all 
around except at the region of anterior commissure. Five ligaments namely the median 
thyroepiglottic ligament, the two vestibular ligaments and the two vocal ligaments are 
attached here from superior to inferior. This attachment forms the anterior commissure 
tendon or the Broyles’ tendon which constitutes an important barrier to the spread of 
laryngeal neoplasms (31). 
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Cricoid cartilage 
              The cricoid cartilage forms a complete cartilaginous ring of the airway and is 
taller posteriorly forming most of the posterior wall of larynx. Cricoid cartilage serves as the 
most important structural support for a functioning larynx since it is a complete ring. The 
posterior lamina is broader than the anterior and the inferior border is flat. The posterior 
lamina extends cranially to articulate with the arytenoids forming the cricoarytenoid joints 
which are crucial joints for voice production. The inferior border is attached to the first 
tracheal ring via the cricotracheal ligament. Since this is the only cartilage that forms a 
complete ring surrounding the airway, it is more prone to injury and is a common site for 
airway narrowing (32). 
 
Arytenoid cartilage 
                       These are paired, three sided pyramids with an anterior process (vocal 
process) and a lateral process (muscular process) and an apex and a base. The vocal process 
attaches to the vocal ligament and the muscular process attaches to the posterior 
cricoarytenoid muscle. The medial surface forms the lateral boundary of the posterior glottis. 
Arytenoids are capable of rocking, gliding and rotatory actions around the cricoarytenoid 
joint. Sitting atop the arytenoid cartilage is the corniculate cartilage. 
 
Corniculate and Cuneiform cartilages 
              They are paired elastic fibrocartilages. Corniculate cartilages (Cartilage of 
Santorini) are located in the posterior part of aryepiglottic fold and they articulate with the 
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apex of arytenoid cartilage through synovial joints. Cuneiform cartilages (Cartilage of 
Wrisberg) are located in the margin of aryepiglottic folds adding rigidity to these folds. 
 
Ligaments of larynx  
 
               The connective tissue of the larynx condenses to form extrinsic and intrinsic 
ligaments. The extrinsic ligaments connect the larynx to the surrounding structures whereas 
the intrinsic ligaments connect the laryngeal cartilages to each other.  
 
    The thyrohyoid ligament, the hyoepiglottic ligament, the glossoepiglottic 
ligament and the cricotracheal ligament are the extrinsic ligaments of larynx. The intrinsic 
ligament defines the skeletal outline of larynx by maintaining the nine cartilages in position. 
These are the quadrangular membrane, conus elasticus and thyroepiglottic ligament.  
 
                The quadrangular membrane lies between the lateral surface of epiglottis 
anteriorly, the medial surface of arytenoid cartilage posteriorly reaching up to the ventricular 
ligament inferiorly. The superior margin of this forms the aryepiglottic fold. Conus elasticus 
arises from the superior border of cricoid cartilage and attaches on the lower anterior border 
of thyroid cartilage forming the cricothyroid membrane. The superior aspect forms the vocal 
ligament. In the subglottis the conus elasticus lies in the submucosal plane (32). 
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Fig. 4 External framework of larynx (adopted from the book Clinical Anatomy by Harold 
Ellis) 
 
Muscles of Larynx      
            
                        Muscles of larynx are divided into intrinsic and extrinsic muscles. Extrinsic 
muscles are responsible for maintaining the position of larynx in the neck whereas intrinsic 
muscles are responsible for maintaining the vocal fold shape and movement. 
                        The intrinsic muscles are connected to the laryngeal cartilages. The intrinsic 
muscles are all paired and move the cartilages of larynx thereby regulating the mechanical 
properties of the larynx. The adductors of vocal cord are the lateral cricoarytenoid, 
thyroarytenoid and the interarytenoid muscles.  
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                    The lateral cricoarytenoid arises from the superior border of lateral part of 
arch of cricoid cartilage and inserts on to the muscular process of the arytenoid. They adducts 
the vocal fold thereby making its edge sharp and passively stiffened.  
            The thyroarytenoid arises from the inner thyroid cartilage and inserts on to the 
vocal process of the arytenoid and anterolateral surface of body of arytenoid. This is mainly 
concerned with maintaining the tension of vocal folds. The medial belly of thyroarytenoid is 
known as the vocalis muscle and it forms the body of the vocal fold. The medial compartment 
of thyroarytenoid muscle has a higher concentration of slow twitch muscle fibres whereas 
the lateral compartment has higher concentration of fast twitch muscle fibres. Thus medial 
compartment is specialised for phonation whereas lateral compartment is specialised for 
vocal fold adduction (33).  
                The posterior cricoarytenoid is the sole muscle which abducts or opens up the 
vocal folds. It originates from the posterior surface of the cricoid cartilage and inserts on to 
the muscular process of the arytenoid (34).   
             Cricothyroid arises from the lateral surface of anterior arch of cricoid 
cartilage and inserts laterally onto the anterior border of inferior cornu of thyroid cartilage 
and posterior part of lower border of thyroid lamina. Cricothyroid muscle stretches the vocal 
cords and is an important muscle for professional singers. 
              Extrinsic laryngeal muscles are primarily strap muscles which maintain the 
position of larynx in neck. They help the intrinsic musculature to work effectively by 
maintaining a stable laryngeal skeleton. The extrinsic muscles are divided into infrahyoid 
and suprahyoid muscles. The infrahyoid muscles are sternohyoid, thyrohyoid, sternothyroid 
and omohyoid. The suprahyoid muscles are digastric, mylohyoid, geniohyoid and stylohyoid.  
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            Fig. 5 Intrinsic muscles of larynx. (Adopted from Netter’s Colour Atlas)                                      
                   
      All intrinsic muscles of larynx are innervated by the recurrent laryngeal nerve 
except for the cricothyroid which is innervated by the superior laryngeal nerve. Recurrent 
laryngeal nerve and superior laryngeal nerve are the branches of the tenth cranial nerve or 
the Vagus nerve. The superior laryngeal nerve branches off the vagus nerve at the inferior 
end of nodose ganglion and divides into internal and external laryngeal nerve near the greater 
cornu of hyoid bone. The external branch supplies the cricothyroid muscle and the internal 
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branch is responsible for innervation of laryngeal mucosa above the level of vocal fold. The 
internal branch enters the larynx after piercing the thyrohyoid membrane along with the 
superior laryngeal artery (34).  
                The recurrent laryngeal nerve branches off the vagus in the upper thorax and 
has got different course on the right and left sides. The right recurrent laryngeal nerve 
branches off the vagus near the right subclavian artery and then travels in the right 
tracheoesophageal groove. The left recurrent laryngeal nerve winds around the aortic arch 
distal to the ligamentum arteriosum, and then enters the tracheoesophageal groove in the 
chest. The right nerve loops around the right subclavian artery and both of them travel 
superiorly towards the larynx. Thus the left has a longer course than the right and is more 
vulnerable to injury. Both the nerves enter the larynx behind the cricothyroid joint  deep to 
the fibres of  inferior constrictors (32). There are also interconnections between the superior 
and recurrent laryngeal nerves, particularly in the interarytenoid muscle (33). 
                  The arterial supply of larynx is derived from the laryngeal branches of 
superior and inferior thyroid arteries and the cricothyroid branch of the superior thyroid 
artery. The lymphatic drainage of larynx is divided by the vocal folds into upper and lower 
drainage groups. The larynx above the vocal folds is drained by vessels that accompany the 
superior laryngeal vein and pierce the thyrohyoid membrane emptying into the upper deep 
cervical lymph nodes. The larynx below the vocal folds drain into the lower deep cervical 
chain through the prelaryngeal and pretracheal nodes. The free edge of vocal fold is devoid 
of lymphatics. 
                  The  lymph nodes of the neck were categorised into different levels by the 
head and neck surgeons at the Memorial Sloan-Kettering Hospital  into six different zones or 
levels on each side (35).  
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Level I: includes the submental (Ia) and submandibular groups (Ib). The submental group is 
confined between the boundaries of submental triangle and the submandibular nodes lies in 
the submandibular triangle.  
Level II: includes the upper jugular group located around the upper third of Internal Jugular 
vein extending from the level of carotid artery bifurcation (surgical landmark) or horizontal 
plane passing through the inferior border of hyoid bone (clinical landmark) inferiorly to the 
skull base superiorly, laterally up to the posterior border of sternocleidomastoid and medially 
up to the lateral border of stylohyoid muscle. Level II node is subdivided into two IIa and IIb   
by the spinal accessory nerve.  
Level III: includes nodes located along the middle third of the internal jugular vein and 
extends from the carotid artery bifurcation superiorly to the junction of the crossing of the 
omohyoid muscle with internal jugular vein (surgical landmark) or from the horizontal plane 
passing through the inferior border of hyoid bone to the inferior border of cricoid cartilage 
(clinical landmark).  
Level IV: these are the lower jugular group and extends from horizontal plane passing 
through the inferior border of cricoid cartilage superiorly to clavicle inferiorly.  
Level V:  includes the posterior triangle group.  
Level VI: nodes include those lying in the anterior central compartment of neck extending 
from the level of hyoid bone superiorly to the suprasternal notch inferiorly. The lateral 
boundaries are the common carotid arteries. The perithyroidal, paratracheal, prelaryngeal 
(Delphian) nodes and nodes along recurrent laryngeal nerves lie in this group (36). 
                    Recently a Level VII group of lymph nodes is being described. This refers to 
the extension of paratracheal nodes below the suprasternal notch up to the level of the 
innominate artery. These are also known as superior mediastinal nodes (37) . 
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Fig. 6 Cervical lymph nodes divided into seven levels (Adopted from Otolaryngol Clin N Am 
45 (2012) 1363-1383 
                        Larynx is divided into three regions or sites namely supraglottis, glottis and 
subglottis. The supraglottis extends superiorly from the tip of the epiglottis to the apex of the 
ventricles and undersurface of the false cords inferiorly. It includes the both the lingual and 
laryngeal surface of the epiglottis, the false cords (ventricular bands), the arytenoids and the 
aryepiglottic folds (laryngeal surfaces only). The inferior limit of supraglottis is a horizontal 
line passing through the lateral margin of the ventricle at its junction with superior surface of 
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true vocal cords. Supraglottis has rich lymphatic supply and therefore tumours involving this 
region has high propensity for cervical lymph node metastasis.  
                The glottis is composed of true vocal cords and the anterior and posterior 
commissures. The posterior two fifths of the vocal fold is cartilaginous and the anterior three 
fifths is membranous. Most of the vibratory function occurs in the membranous portion. The 
inferior limit of glottis is 1cm inferior to the inferior limit of supraglottis (31). The anterior 
commissure lies midway between the thyroid notch and lower border of thyroid cartilage in  
males  whereas  it lies  at the junction of  upper  one third  and  lower two thirds  in  females.  
Subglottis extends from the inferior limit of glottis to the inferior border of cricoid cartilage. 
 
 
 
Fig. 7   Normal larynx. 
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Histology of larynx                      
                       The mucosa of larynx is lined predominantly by pseudostratified ciliated 
columnar epithelium or the respiratory epithelium except the vocal folds, the edges of 
aryepiglottic folds, the anterior surface and upper portion of posterior surface of epiglottis. 
These areas are lined by stratified squamous epithelium (32). The true vocal cords are lined 
by stratified squamous epithelium better suited to withstand the trauma of vocal fold contact. 
The subglottis is also lined by pseudostratified columnar epithelium.  
 
Fig. 8 Histology of laryngeal mucosa ( Adopted from Mills SE, Fechner RE, Pathology of the 
larynx , Atlas of Head and Neck Pathology Series ) 
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 Microanatomy of the vocal fold  
               The stucture  of vocal fold is very complex and is composed  of five layers. 
The outer epithelial layer acts like a capsule and helps in maintaining the shape of the vocal 
fold. The vibratory surface of this is lined by stratified squamous epithelium. Beneath the 
epithelium lies the Reinke’s space and the vocal ligament. The superficial layer of lamina 
propria forms the Reinke’s space and it is composed of loose fibrous components and matrix 
with a few fibroblasts. The intermediate and deep layers form the vocal ligament and lies 
immediately beneath the Reinke’s space. The intermediate layer does not contain fibroblasts 
and is mainly made of elastic fibres. The deep layer is rich in fibroblasts and is primarily 
composed of collagenous fibres. This structure is not uniform throughout the entire length of 
vocal cord. At the anterior end of the vocal cord, the intermediate layer becomes thickened 
to form an oval mass which is known as anterior macula flava. It inserts anteriorly into the 
anterior commissure tendon and is made of fibroblasts, stroma and elastic fibres. Similarly at 
the posterior end, the intermediate layer becomes thickened to form the posterior macula 
flava, which is attached to the vocal process of the arytenoid cartilage. Both of them acts as 
cushions that protects the ends of vocal cord from mechanical damage caused by contact or 
vibrations. Deep to lamina propria lies the thyroarytenoid or the vocalis muscle. 
                     Even though the vocal fold is composed of five layers, mechanically it acts 
like a three layered structure. The three layers are the cover, transition and the body. The 
cover is formed by the epithelium and the Reinke’s space, the transition by the intermediate 
and deep layers of the lamina propria and the body by the vocalis muscle. Recent research 
has shown an additional layer of basement membrane connecting the epithelium to the 
superficial  layer of lamina propria (33) . 
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   Fig. 9 Microanatomy of vocal cord ( Adopted from Tom Harris et al, The Voice Clinic 
Handbook, Whurr Publishers, 1998 ) 
                     There are two potential spaces of larynx namely the pre epiglottic space and 
the paraglottic space. The pre epiglottic space is bounded superiorly by the hyoepiglottic 
ligament, anteriorly by the thyroid cartilage and the thyrohyoid membrane, posteriorly by the 
epiglottis and the thyroepiglottic ligament. Laterally the pre epiglottic space opens into the 
paraglottic space. The pre epiglottic space is composed of fat and areolar tissue and is 
frequently invaded by tumours through the small fenestrations over the posterior surface of 
epiglottis. The paraglottic space lies lateral to the true and false cords. It is bounded medially 
by the quadrangular membrane, the ventricle and conus elasticus, laterally by the thyroid 
cartilage anteriorly and the mucosa of the medial wall of pyriform sinus posteriorly, and 
inferolaterally by the cricothyroid membrane. The paraglottic space together with the pre 
epiglottic space forms a horseshoe shaped fatty space around the internal laryngeal structures 
(29). 
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BENIGN LARYNGEAL DISORDERS 
   
                         Voice plays a key role in one’s identity and vocal dysfunction has a significant 
psychosocial impact on one’s life. Voice disorders may result from pathologies affecting the 
vocal cords. These are broadly classified into benign and malignant disorders. Professional 
voice users like teachers, singers, lawyers etc. are at risk of developing benign vocal cord 
disorders. Sulkowski et al (38) analysed 1261 cases of occupational voice disorders over a 5 
year period and reported that 66% of these patients were primary  school teachers and 55% of 
referrals were at 51- 60 years of age. Benign lesions of vocal cord are noncancerous growth of 
abnormal tissue occurring in the vocal cords. According to the nomenclature system put 
forward by Rosen et al (39), they are referred to as Benign Vocal Fold Lesions (BVFLs). They 
include nine distinct vocal fold lesions. 
 
1) Vocal fold nodules  
2) Vocal  fold polyps 
3) Vocal fold cysts - subepithelial 
4) Vocal fold cysts - ligamental 
5) Pseudocysts 
6) Reactive lesions  
7) Nonspecific vocal fold lesions ( NSVFL ) 
8) Vocal fold fibrous mass- subepithelial 
9) Vocal fold fibrous mass- subligamental. 
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                     Others include intracordal scarring, granulomas, papillomas, Reinke’s oedema, 
vocal cord ectasia and leukoplakia involving the cords. Singhal et al (40)  conducted a study to 
identify the demographic characteristics and symptomatology of 50 cases of benign tumours 
of larynx and concluded that majority of these tumours occurred in males and 66% of patients 
had vocal cord polyps with hoarseness of voice being the most prominent presenting symptom. 
 
VOCAL NODULE: 
                      Vocal nodules are defined as bilateral small swellings which are less than 
3mm in diameter. These are seen in children, more commonly in boys and in professional 
voice users, predominantly in women. They are also known as singer’s nodes, screamer’s 
nodes or teacher’s nodules. Patients present with hoarseness, frequent voice breaks and voice 
fatigue. They are usually located over the free edge of the vocal cord at the junction of 
anterior one third and posterior two thirds (29). This is because this is the region where the 
vocal cords are subjected to maximum shearing and collision forces. The repeated collision 
leads to formation of localised vascular congestion and oedema and in long run leads to 
hyalinisation of the Reinke’s space with thickening of overlying epithelium and development 
of epithelial hyperplasia.  
                   The histology of nodule is very important to differentiate it from vocal cord 
polyps. In vocal nodules, epithelium shows hyperplasia with parakeratosis with thickening 
of basement membrane and fibrosis of lamina propria (41). Stroboscopy shows an hour glass 
closure of glottis. Treatment options include medical management with antireflux measures 
and speech therapy. Surgical option may be considered as a last option for patients who fail 
several sessions of speech therapy and remain symptomatic. Surgical techniques include 
microsurgical methods or laser excision. 
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Fig. 10 Vocal fold nodules A. During inspiration B. During Phonation (Adopted from 
 
Otolaryngol Clin N Am40 (2007) 1091–1108) 
 
 
 
VOCAL FOLD POLYPS 
                 Vocal polyp is a benign swelling greater than 3mm arising from the free edge 
of vocal fold. They affect men more than women and are frequently seen between ages of 30 
and 50 years. Aetiological factors include intense vocal abuse as yelling or shouting, history 
of aspirin or anticoagulant use, history of trauma like endotracheal intubation (22). They 
affect men more than women. Histological features are characterised by breakage of 
capillaries in the Reinke’s space with surrounding oedema and deposition of amorphous 
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material and hemosiderin. The basement membrane in case of polyps is normal or thinned 
out. Polyps may be broad based or pedunculated, haemorrhagic or non haemorrhagic. On 
stroboscopy, small polyps show intact mucosal wave but phase asymmetry due to impaired 
phase closure and mass effect whereas large polyps show decreased mucosal wave amplitude. 
Polyps are removed by surgical excision under general anaesthesia followed by speech 
therapy. 
 
 
 
Fig. 11 Right vocal cord polyp 
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VOCAL CORD CYSTS 
                   Cysts are subepidermal epithelial-lined sacs which are located within the 
lamina propria. They are of two types: a mucus retention cyst and an epidermoid cyst. Mucus 
retention cyst develop when the duct of a mucus gland gets blocked, retaining the secretions 
(38). It is lined by cuboidal or low columnar epithelium. It is usually unilateral and is found 
on the free edge of the vocal fold (29).  Epidermoid cysts may develop from congenital cell 
rests or as a result of microinclusion of epithelium from surface trauma. These are lined by 
squamous epithelium and are filled with cholesterol and keratin debris. Stroboscopy reveals 
asymmetric vocal folds with a subepithelial mass and absent mucosal wave. Sometimes the 
cyst may rupture spontaneously and if the resultant opening is small as compared to the cyst, 
it forms an open cyst (31). 
 
Fig. 12 Right vocal cord cyst. 
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VOCAL CORD PAPILLOMA 
                Respiratory papillomatosis is a chronic infection of viral etiology caused by 
Human Papilloma virus (HPV) namely HPV 6 and 11. It manifests as proliferation of benign 
squamous papillomas in the upper aerodigestive tract. This is more commonly seen among 
children. There are two forms of papilloma, an aggressive form that occurs in childhood and a 
less aggressive form that typically occurs in adults. They appear as cauliflower like sessile or 
pedunculated pinkish or whitish masses and are most commonly found in the transition zone 
between squamous and columnar epithelium. Ciliated epithelium undergoes squamous 
metaplasia when exposed to repeated trauma and this is why RRP is more common in patients 
with gastroesophageal reflux disease (42). Surgical removal using cold steel, microdebrider, 
using laser are the various treatment options available. Adjuvant treatment modalities like  
interferon  acyclovir, ribavirin, cidofovir etc. have been reported to be effective in recurrent 
cases (43). 
 
Fig. 13 Laryngeal Papillomatosis. 
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REINKE’S EDEMA 
 
                  Reinke’s oedema is a condition in which the vocal cords become chronically or 
irreversibly swollen. This is also termed as polypoid corditis or vocal polyposis or smokers’ 
larynx. Reinke’s oedema appears as an out pouching from the membranous vocal folds 
sometimes resembling a water balloon. Smoking, gastroesophageal reflux, voice strain, 
hypothyroidism play an important role in its development.  Goswami et al  (44) conducted a 
clinicopathological analysis  of 92 cases of Reinke’s oedema  and  reported that this was mostly 
found in middle aged persons with a male predilection and a strong association with smoking. 
Histologically Reinke’s oedema is characterised by lakes of oedema in the Reinke’s space with 
extravasated erythrocytes and thickening of the walls of the subepithelial vessels and 
thickening of basement membrane. A severity grading for Reinke’s oedema was put forward 
by  Savic (29). 
 
The grading is as follows  
Grade 1-Marginal edge oedema 
Grade 2-Obvious sessile swelling thrown over the vocalis muscle during phonation. 
Grade 3-Large bag like swellings filled with fluid. 
Grade 4-Partially obstructing lesions with medial border in contact in almost entire length. 
 
                     The patient presents with symptoms of change in voice with a deepening of the 
pitch of voice, effortful speaking and sometimes choking episodes. The  voice  becomes low 
pitched due to increase  in the  mass  of  vocal  folds and the  patient will be unable  to produce  
high notes. The voice is typically said to be raspy. On stroboscopy the mucosal wave will be 
decreased due to the mass effect of the oedema with phase asymmetry due to ball valving and 
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asymmetric oedema. Treatment options include reduction glottoplasty with cessation of 
smoking. 
 
 
.  
Fig. 14 Bilateral polypoid corditis (Adopted from Otolaryngol Clin N Am40 (2007) 1091– 
 
1108) 
 
                  
VOCAL CORD KERATOSIS 
  
                       Vocal cord keratosis is one of the premalignant lesions of larynx. It presents as 
a keratinised whitish plaque on the epithelium of the vocal cord. This is also called leukoplakia 
of the cords. The chance of transformation into malignancy is about 8% (45). Very early lesions  
show hyperkeratosis and parakeratosis without cellular atypia  whereas squamous dysplasia  
shows cellular atypia which may be mild, moderate, severe or carcinoma in situ (31). Treatment 
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is by microsurgical excision and biopsy. Malignant transformation of mild dysplasia is reported 
to be 11% where as that of severe dysplasia or carcinoma in situ is reported to be as high as 
45%.  So a long term follow up of such patients is absolutely necessary. 
 
 
 
Fig. 15 Left vocal fold keratosis 
 
GRANULOMAS 
               Granulomas occur following trauma to the vocal cords most commonly in 
patients with laryngopharyngeal reflux, with excessive throat clearing and following 
endotracheal intubation. They usually do not cause any voice disturbances  since they are 
found on the cartilaginous part of the cords (38). Large granulomas can cause hoarseness and 
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even difficulty in breathing. Granulomas can also occur in the larynx secondary to specific 
granulomatous diseases of larynx like tuberculosis, leprosy, leishmaniasis, syphilis, 
blastomycosis etc. Intubation granulomas were more frequently found in females. This was 
attributed to anatomic peculiarities of female larynx such as small size allowing more contact 
of the endotracheal tube with the airway mucosa. Granulomas frequently occur in the 
posterior glottis because the perichondrium over the vocal process is very fragile 
predisposing to formation of ulcers (46). Histopathological examination shows mild 
epithelial hyperplasia with severe inflammation and vessel proliferation in the centre. 
 
 
 
 
Fig. 16 Left Vocal process granuloma (Adopted from Otolaryngol Clin N Am40 (2007) 1091– 
 
1108) 
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MICROVASCULAR LESIONS 
                        These include varices or capillary ectasias. They are usually found over the 
superior or medial surface of mid membranous portion of the vocal folds. They are aberrant 
vessels of microcirculation lying within the  superficial layer of lamina propria (38). They 
may also be associated with vocal cord haemorrhage, polyp or even scarring. Pulsed 
angiolytic lasers like KTP lasers have been reported to be useful in treating such lesions. 
 
PREMALIGNANT LESIONS OF LARYNX.                    
                   Premalignant lesions of larynx is defined by WHO as “ morphological 
alterations of  mucosa caused by chronic local irritative factors or referable to local 
expression of generalised illness, presenting a higher probability of degeneration into 
carcinoma with respect to  surrounding mucosa” (47). Laryngeal precancerous lesions have 
no specific macroscopic appearance and are variously referred as chronic laryngitis, 
keratosis, leukoplakia, erythroplakia, hyperplastic-dysplastic lesions. Whatever the 
macroscopic appearance, the histopathological feature is the key for management of such 
lesions.  
       World Health Organisation has classified premalignant lesions of larynx into six groups. 
1) Hyperplasia. 
2) Keratosis.  
3) Mild dysplasia. 
4) Moderate dysplasia. 
5)  Severe dysplasia. 
6) Carcinoma in situ (CIS).  
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                  Another well known classification is the Ljubljana classification. According 
to this the premalignant lesions are classified as   
 
1)  Simple hyperplasia. 
2) Basal / parabasal hyperplasia. 
3) Atypical hyperplasia. 
4) Carcinoma in situ (48). 
                         
                     Histologically very early lesions may manifest hyperkeratosis or parakeratosis 
only without cellular atypia whereas dysplastic lesions demonstrate cellular atypia with loss 
of maturation or stratification. In mild dysplasia the changes are limited to basal one third of 
the epithelium whereas in moderate it involves up to two thirds of the epithelium and in 
severe dysplasia changes are seen in more than two thirds of the thickness of the epithelium.  
Carcinoma in situ is characterised by involvement of full thickness of the epithelium but 
without violation of basement membrane and stromal invasion.  
             Visual appearance of the lesion does not predict the histological nature and 
therefore biopsy is a must for the diagnosis and further management. The rate of malignant 
transformation for severe dysplasia and carcinoma in situ is as high as 30 to 45% (31). 
Treatment modalities include microlaryngoscopy and excision by conventional method or 
with CO2 laser and by radiotherapy. All these patients require a close follow up due to the 
high risk of malignant transformation (48). 
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MALIGNANT TUMOURS OF LARYNX 
                            Laryngeal cancer is reported to be the eleventh most common cancer 
worldwide and second most common malignancy of upper aerodigestive tract (38). Among 
them glottic cancer are the most common. The incidence is about 30-35% in the supraglottic 
region, 60-65% in the glottis and 5% in the subglottic region. World health Organisation has 
put forward a histological classification for tumours of larynx. These are broadly classified into 
epithelial tumours, malignant salivary gland tumours, malignant soft tissue tumours, malignant 
tumours of bone and cartilage, haematolymphoid tumours and secondary laryngeal 
malignancies (31). Squamous cell carcinoma accounts for 85 to 95% of malignant laryngeal 
tumours arising from the epithelial lining of larynx. Glottic carcinomas are reported to be the 
most common in United States accounting to about 59% and subglottic carcinomas were rare 
accounting for about 1% (38). Laryngeal cancer is common in males with  an incidence of 5.3 
per 100000 population compared to females where the incidence rate is 1 per 100000 
population (49). 
 
Aetiology of Laryngeal cancer. 
                      Smoking and alcohol are considered to be primary risk factors for laryngeal 
cancer. Human Papilloma virus, chemical carcinogens, prior exposure to radiation, family 
history of head and neck malignancies and diet are considered to be other risk factors.   Smokers 
have a 10 to 20 fold  increase  in laryngeal cancer compared to non smokers  and the risk 
sharply decreases with cessation of smoking (38). Tobacco and alcohol are the two strong 
etiological factors for the development of Head and Neck Squamous Cell Carcinoma acting 
both independently and synergistically (50). Alcohol consumption is strongly linked to 
supraglottic carcinoma whereas smoking is strongly associated with glottic carcinoma. The risk 
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is proportional to the amount and duration of tobacco or alcohol consumption and decreases 
slowly after cessation but does not return to baseline value for at least 20 years.   It has been 
demonstrated that derivatives of burning cigarette such as nitrosamines and polycyclic aromatic 
hydrocarbons are potential carcinogens for laryngeal epithelium. They produce mutations in 
the DNA, disrupt the normal cell cycle leading to proliferation of tumour cells leading to 
carcinogenesis. Also smoking black (air cured) tobacco is associated with greater risk due to 
greater amount of carcinogens in it. Alcohol causes chronic inflammation of the lining of the 
larynx resulting in genetic mutations leading to carcinogenesis. Also chronic alcoholism leads 
to malnutrition, changes in immunoglobulin level and vitamin deficiencies especially Vit A 
and E which are important antioxidants (51). 
                        Gastroesophageal reflux is also being considered as a risk factor for laryngeal 
carcinoma as this causes chronic laryngeal irritation but the causality of the association is yet 
to be proven. The role of reflux was more clearly demonstrated in patients with laryngeal cancer 
who were non smokers. A significant association with  GERD was proposed in a retrospective 
study conducted by Freije et al (52) on patients with laryngeal cancer without any other risk 
factors. In a study conducted  by  Francis et al (53), no association was found  between 
laryngopharyngeal reflux and laryngeal cancer. Johnston et al (54) have reported that refluxed 
pepsin can promote proliferation of laryngeal and pharyngeal epithelial cells . 
                        Human Papilloma Virus (HPV) subtypes 16 and 18 have been closely related to 
laryngeal cancer and is considered as an independent risk factor for laryngeal cancer. HPV 16 
is the predominant genotype identified in head and neck tumours. It has been associated with 
verrucous cell carcinoma and squamous cell carcinoma of larynx. HPV integrates into the host 
cell genome and the viral particles replicate in the basal cell layer. An epithelial cell infected 
by HPV produces more tumorigenic cells. 
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                        Occupational exposure to carcinogens in work place has been attributed to 
carcinoma larynx. Cement dust, fertilizers, polycyclic hydrocarbons, petroleum derivatives, 
wood and metal dust are potential carcinogens. Chemical solvents acts synergistically with 
tobacco and alcohol and doubles the risk of laryngeal cancer (55).     
                        Genetic predisposition has also been shown to have a role in the pathogenesis 
of laryngeal cancer. A small number of patients who have no exogenous risk factors develop 
tumour and this can be attributed to the familial inheritance. The risk is higher when there is 
family history of cancer in a first degree relative and is further increased if the neoplasm was 
in the head and neck region (56). 
                        Recently the role of Helicobacter pylori as an etiological agent for laryngeal 
cancer have been studied. Several studies have yielded conflicting results.  H. pylori infection 
is considered to cause proliferation  of epithelial cells which may progress to  laryngeal 
carcinoma (57). Rezaii  et al (58) studied the relationship between H. pylori seropositivity and 
hypopharyngeal and laryngeal carcinoma and concluded that H. pylori seropositivity was more 
in patients with laryngeal carcinoma than in the control group. Another study conducted by 
Genc et al (57)  failed to show an association between H. pylori and laryngeal carcinoma. 
Immunohistochemical staining for H. pylori was done in the 59 laryngeal specimens in this 
study, out of which 31 were laryngeal cancer and 28 were benign laryngeal pathologies. 
Pirzadeh et al (1) investigated the possible role of H. pylori as a cause of squamous cell 
carcinoma of larynx by doing rapid urease test on laryngeal specimens, but failed to prove an 
association as an etiological agent for laryngeal cancer. 
                     The multiple aetiological factors act on the various levels of the molecular 
structure of the epithelial cell lining of larynx and act as carcinogens. Thus a series of events  
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occur and there is a progression of normal mucosa to pre malignant lesions and then to invasive 
cancer. 
  
         Progression of normal epithelium to premalignant and to invasive disease in  
                                                      squamous  cell carcinoma (59) 
                                                          
                                                           Normal mucosa 
                                            
                                                                 Hyperplasia 
                                                                      
                                                  Dysplasia (Mild - Moderate - Severe)  
                                                                         
                                                         Carcinoma in situ 
                                                                      
                                                        Invasive carcinoma . 
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                   A variant of squamous cell carcinoma is verrucous carcinoma. It appears as a 
predominant exophytic growth and histologically characterised by well differentiated 
keratinising epithelium with pushing margins. The squamous epithelium lacks the cytological 
criteria for malignancy which differentiates it from conventional squamous cell carcinoma. 
Verrucous carcinoma usually do not metastasize to cervical lymph nodes. The treatment of 
choice is surgical excision as these tumours are less radiosensitive (31).  Basaloid squamous 
cell carcinoma is a rare and highly malignant form of squamous cell carcinoma more 
commonly involving the supraglottic larynx and pyriform sinus. Other variants of SCC 
includes adenosquamous carcinoma, acantholytic squamous carcinoma and papillary 
squamous carcinoma. 
                        A typical patient with laryngeal cancer presents with hoarseness, dysphagia, 
odynophagia, dyspnoea, referred otalgia and aspiration. Glottic carcinomas present earlier than 
supraglottic and subglottic tumours because any small lesion in the vocal cord can cause change 
in voice. Supraglottic tumours usually presents with dysphagia, odynophagia and neck nodes 
whereas subglottic tumours commonly presents with airway obstruction (60). Hoarseness in 
supraglottic and subglottic tumours will be a late manifestation. 
                    Supraglottic tumours may even present with cervical lymphadenopathy whereas 
glottis tumours seldom presents with lymphadenopathy because of poor lymphatic supply to 
glottis. Supraglottic tumours usually metastasize to level 2, 3 and 4 lymph nodes. Laryngeal 
examination shows an ulcerative, exophytic or polypoidal lesion. Sometimes it can even 
present as a laryngocoele. Carcinoma arising from the ventriculosaccular region may present  
as a fullness of the ventricular region (31). 
                   Evaluation of a patient presenting with laryngeal carcinoma begins with a 
thorough history and clinical examination. Flexible fibreoptic laryngoscopy is extremely 
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helpful as it helps to visualise the hidden areas of larynx and permits photographic and video 
documentation. Imaging provides additional information which helps in staging of the disease 
and further surgical planning. CT and MRI are the major imaging modalities which helps in 
visualisation of extent of disease (60). MRI is superior to CT in assessing cartilage invasion 
and discrimination of soft tissue structures. 
                 Staging the disease is very important for optimal treatment. The TNM staging 
for laryngeal carcinoma is as follows: 
 
Primary tumour (T) 
 Tx- Primary tumour cannot be assessed. 
 T0- No evidence of primary tumour. 
 Tis- Carcinoma in situ. 
Supraglottis: 
 T1-Tumour limited to one subsite of supraglottis with normal vocal cord mobility. 
 T2-Tumour invades mucosa of more than one adjacent subsite of supraglottis or glottis 
or region outside the supraglottis (mucosa of base of tongue, vallecula or medial wall 
of pyriform sinus) with normal vocal cord mobility. 
 T3-Tumour limited to the larynx with vocal cord fixation and/or invades any of the 
following: postcricoid area, pre epiglottic tissue, paraglottic space and /or minor thyroid 
cartilage erosion (inner cortex) 
 T4a-Tumour invades through the thyroid cartilage and/or invades tissues beyond the 
larynx (eg. trachea, soft tissues of the neck including deep extrinsic muscles of the 
tongue, strap muscles, thyroid or oesophagus.) 
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 T4b-Tumour invades prevertebral space, encases carotid artery, or invades mediastinal 
structures. 
 
Glottis: 
 T1-Tumour limited to the vocal cords, may involve anterior and posterior commissure, 
with normal vocal cord mobility 
         T1a-Tumour limited to one vocal cord. 
         T1b-Tumour involves both vocal cords. 
 T2-Tumour extends to supraglottis and/or subglottis or with impaired vocal cord 
mobility. 
 T3-Tumour limited to the larynx with vocal cord fixation and/or invades paraglottic 
space and/or minor thyroid cartilage erosion (inner cortex). 
 T4a-Tumour invades through thyroid cartilage and/or invades tissues beyond the 
larynx. (eg. trachea, soft tissues of the neck including deep extrinsic muscles of the 
tongue, strap muscles, thyroid or oesophagus.) 
 T4b-Tumour invades prevertebral space, encases carotid artery, or invades mediastinal 
structures. 
 
Subglottis: 
 T1-Tumour limited to the subglottis. 
 T2-Tumour extends to vocal cords with normal  or impaired cord mobility 
 T3-Tumour limited to larynx with vocal cord fixation. 
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 T4-Tumour invades cricoid or thyroid cartilage and/or invades tissues beyond the 
larynx (eg. trachea, soft tissues of the neck including deep extrinsic muscles of the 
tongue, strap muscles, thyroid or oesophagus.) 
 T4b-Tumour invades prevertebral space, encases carotid artery, or invades mediastinal 
structures. 
 
Regional lymph nodes (N) 
 Nx- Regional lymph nodes cannot be assessed. 
 N0- No regional lymph node metastasis. 
 N1- Metastasis in a single ipsilateral lymph node less than or equal to 3cm in greatest 
dimension. 
 N2-Metastasis in a single ipsilateral lymph node >3cm but not >6cm in greatest 
dimension, or in multiple ipsilateral lymph nodes none >6cm in greatest dimension, or 
in bilateral or contralateral lymph nodes, none >6cm in greatest dimension. 
 N2a- Metastasis in a single ipsilateral lymph node >3cm but not >6cm in greatest 
dimension. 
 N2b-Metastasis in multiple ipsilateral lymph nodes none >6cm in greatest dimension. 
 N2c- Metastasis in bilateral or contralateral lymph nodes, none >6cm in greatest 
dimension. 
 N3-Metastasis in a lymph node >6cm in greatest dimension. 
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Distant metastasis (M) 
 Mx-Distant metastasis cannot be assessed. 
 M0-No distant metastasis 
 M1-Distant metastasis 
 
Treatment of Laryngeal Cancer  
                       A microlaryngoscopy and biopsy gives a histopathological diagnosis followed 
by which definitive treatment is planned. Treatment modalities include surgery, radiation, 
chemotherapy or a combination of the three. Management depends upon the stage of the 
tumour. As a general rule, early disease is managed by single modality treatment whereas 
advanced disease is managed by combined modality treatment. Larynx has got indispensable 
role in speech and communication and so preservation of voice is very important in 
management of early laryngeal cancer. Finally the choice of treatment modality depends on 
patient’s wishes, functional outcome, reliability in follow up and patient’s general condition. 
                        According to AJCC, early stage glottis tumours are T1 and T2 tumours with no 
regional lymph node involvement and lacking distant metastasis. Early glottis tumours can be 
treated surgically or by radiotherapy. Surgical options have evolved from partial 
laryngectomies by external approaches in the past to transoral endoscopic laser resections. 
Transoral laser resection has established its role in the management of early laryngeal cancer. 
With carbon dioxide laser under microscopic magnification the lesion is removed in piecemeal. 
With laser excision, the postoperative pain is very minimal. Other advantages include short 
treatment time and short duration of hospital stay.  
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The European Laryngological Society (ELS) Working Committee has classified cordectomies 
into following categories (61). 
         Type I: Subepithelial cordectomy (resection of the epithelium alone)     
         Type II: Subligamental cordectomy (resection of epithelium, Reinke’s space and   vocal 
                        ligament) 
         Type III: Transmuscular cordectomy (resection through the vocalis muscle) 
         Type IV:Total cordectomy (resection of the cord up to the anterior commissure) 
         Type V: Extended cordectomy. This is sub classified as 
                  Va: resection up to the contralateral vocal cord including the anterior commissure. 
                  Vb: resection including arytenoids. 
                  Vc: resection including subglottis. 
                  Vd: resection including the ventricle. 
         Type VI: Anterior commissurectomy with bilateral anterior cordectomy. 
                     Also patients can be offered revision laser surgeries, conservational laryngeal 
surgeries, total laryngectomy or radiotherapy in case of persistent or recurrent disease. Open 
surgical procedures for early glottic cancer are classified as organ preservation surgeries with 
the aim of preserving speech and swallowing and avoiding creation of a permanent 
tracheostomy. The prerequisite for all patients who are planned for conservational laryngeal 
surgeries is an adequate pulmonary reserve as all of them will face varying degrees of aspiration 
during the postoperative period. The surgical procedures include cordectomy, vertical partial 
hemilaryngectomy, frontolateral hemilaryngectomy and supracricoid laryngectomy.  
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                  The most important prognostic factor is the stage of the disease and the N stage 
is more important in predicting the survival than the T stage. Other important prognostic factor 
is the site of the disease. Glottic carcinoma has got the best prognosis whereas subglottic 
cancers have the worst prognosis (31). All laryngeal cancer patients require a strict follow up. 
Most of the recurrences occur in the first 2 years after primary treatment. According to NCCN 
guidelines, the follow up for laryngeal cancer is every 1-3 months for the first year, then every 
6 months for the next one year and yearly for the next 3 years. 
 
Fig. 17. Carcinoma of the left vocal cord. 
 
GASTROESOPHAGEAL REFLUX DISEASE. 
                Gastroesophageal reflux is defined as the retrograde movement of gastric 
contents into the oesophagus in the absence of belching or vomiting. When the reflux is 
manifested with clinical symptoms and complications, it is termed gastroesophageal reflux 
disease. When the reflux affects the laryngopharynx, it is termed as laryngopharyngeal reflux 
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(62). GERD is a multifactorial disease where dietary factors, environmental factors and host 
factors play a very important role. A thorough knowledge of the anatomy and physiology of 
oesophagus is essential to understand the pathology of reflux disease. 
 Anatomy of oesophagus. 
                       The oesophagus is a muscular tube connecting the pharynx to the stomach and 
acts as a conduit for the passage of material from pharynx to the stomach. Upper oesophageal 
sphincter (UES) forms the proximal margin of tubular oesophagus correlating anatomically 
with the junction of inferior constrictor with cricopharyngeus. The oesophagus extends distally 
18-26 cm from the UES through the posterior mediastinum to end in the lower oesophageal 
sphincter. Upper oesophageal sphincter is normally closed and opens for specific physiologic 
demands as swallowing or belching. UES is the final gatekeeper of antireflux mechanism. Once 
it fails functioning all the head and neck manifestations of reflux disease appear. The lower 
oesophageal sphincter (LES) is not anatomically distinct as the upper oesophageal sphincter 
and is a 2-4 cm long focus of tonically contracted thickened circular smooth muscle lying 
within the diaphragmatic hiatus. LES is the most critical antireflux defence mechanism 
protecting oesophagus from reflux of gastric contents. Contraction of LES results in circular 
closure whereas relaxation occurs during swallowing, belching or vomiting. LES should 
maintain a higher resting pressure than stomach to prevent reflux. GER occurs when there is a 
reversal of gastric to LES pressure gradient (63).  
                       Histologically oesophagus is composed of four layers namely mucosa, 
submucosa, muscularis propria and adventitia. The oesophagus lacks serosa which makes it 
unique to the rest of gastrointestinal tract. The muscularis propria is composed of both skeletal 
muscles and smooth muscles. The proximal 5% to 33% is skeletal muscle, the middle 35% to 
40% is mixed and the distal 50% to 60% is smooth muscle. These muscles are arranged into 
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inner circular and outer longitudinal layer. Vagus nerve innervates the smooth muscle and 
thereby controls the peristalsis under physiologic conditions.  Oesophagus is also innervated 
by two nerve plexus namely Meissner’s plexus and Myenteric plexus. Meissner’s plexus is 
located in the submucosa and the Myenteric plexus or Auerbach’s plexus is located between 
two muscle layers (64). The Meissner’s complex is the site of afferent sensory input whereas 
myenteric plexus is concerned with oesophageal peristalsis. Excitatory stimulation from 
acetylcholine results in contraction of circular and longitudinal muscle fibres, whereas 
inhibitory neurons mainly affect the circular muscle fibres via nitric oxide. 
 
 
Fig. 18. Cross sectional anatomy of oesophagus (Adopted from Otolaryngol Clin North Am. 2013  
Dec; 46(6):1023–41. Normal oesophageal physiology and laryngopharyngeal reflux.) 
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OESOPHAGEAL PHYSIOLOGY 
                  
                 Functionally, the UES, the oesophageal body, and the LES acts in a coordinated 
manner to allow normal swallowing. Swallowing begins when a food bolus is propelled into  
the pharynx from the mouth. The oropharyngeal phase of swallowing is voluntary, whereas  
the oesophageal phase is involuntary. During swallowing, the larynx is elevated and the 
epiglottis seals the airway. A rapidly progressing pharyngeal contraction then transfers the 
bolus through the relaxed UES into the oesophagus. As the UES closes, a progressive circular 
contraction begins in the upper oesophagus and proceeds distally along the oesophageal body to 
propel the bolus through the relaxed LES. Peristaltic pressures  normally ranging from 30 to 180 
mmHg are generated (65).The measured pressure tends to be lower in the more proximal portions 
of the oesophagus and greater in the distal smooth muscle portions. The pressures may also vary 
with the consistency of the bolus itself. The LES subsequently closes with a prolonged contraction, 
preventing movement back into the oesophagus. The mechanical effect of peristalsis is a stripping 
wave that strips the oesophagus clean from its proximal to its distal end. Secondary peristalsis is a 
progressive contraction in the oesophageal body that is induced by stimulation of sensory receptors, 
rather than a swallow. Distention by residual food bolus or the refluxed gastric contents are usually 
the stimulants. 
 
Pathophysiology of GERD. 
 
 
                Gastroesophageal reflux disease is a very common disease entity nowadays and 
approximately 25 million to 75 million people in the United States are affected by this disease. 
GERD usually presents with a wide variety of symptoms, the most common being heartburn 
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and regurgitation. Several factors are being implicated in the pathogenesis of   GERD which 
include oesophagogastric junction, oesophageal acid clearance, oesophageal mucosal 
resistance, upper oesophageal sphincter. As explained earlier, the lower oesophageal sphincter 
is responsible for maintaining a high pressure zone between the oesophagus and the stomach. 
The LES relaxes normally during swallowing and allows the passage of food bolus into the 
stomach. Sometimes the LES relaxes independent of swallowing. This is termed as transient 
LES relaxation and this lasts longer than normal LES relaxation.  They occur in response to 
vagal sensory and motor nerve stimulation due to gastric distension (66). This transient 
relaxation is considered to be most important pathology in patients with GERD. In them, the 
transient relaxations occur more frequently than normal.  
 
  
                    The crural diaphragm provides structural support and contributes to LES 
competence. The presence of a hiatal hernia widens the diaphragmatic hiatus and impair the 
function of crural diaphragm as an external sphincter worsening the reflux.  LES pressure can 
also be altered with fatty foods, ethanol, cola, drugs like calcium channel blockers, diazepam 
etc. Thus a defective lower oesophageal sphincter increases the volume of gastric contents that 
reflux into the oesophagus. 
 
                         
                        Increased oesophageal acid exposure is another factor considered in the 
pathophysiology of GERD. Oesophageal acid clearance occurs normally by means of 
oesophageal peristalsis and swallowed salivary bicarbonate. Peristalsis clears the gastric 
refluxate and salivary bicarbonate neutralises the remaining acid (66). Prompt clearance of the 
refluxate reduces the duration of the oesophageal mucosa being exposed to the acid. Both 
primary and secondary oesophageal peristalsis contributes to oesophageal acid clearance.  
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Peristaltic dysfunction and re- reflux are thought to be two mechanisms of impaired acid 
clearance. It has been shown that the frequency of secondary oesophageal peristalsis was lower 
in patients with GERD. 
 
 
                       Another factor that protects the oesophageal mucosa from the refluxate is the 
resistance offered by the oesophageal mucosa. This resistance is offered by a complex of layers 
formed by the mucus, unstirred water layer, cell membrane, intercellular bridges at the 
epithelial level, and the buffering system all of which acts as a barrier to mucosal injury. The 
oesophagus also produces bicarbonate which buffers the acid. Any breach in this barrier can 
aggravate the reflux manifestations (62).  Pepsin is said to damage the oesophageal mucosa by 
digesting epithelial protein. 
 
                          
                       GERD has been associated with multiple risk factors. Studies have reported that 
male sex has a higher incidence of oesophagitis. Obese individuals and those with hiatus hernia 
are more prone for reflux symptoms. The presence of a hiatal hernia makes the lower 
oesophageal sphincter less competent with defective peristalsis leading to acid reflux and 
increased mucosal damage. Also an association with scleroderma and patients with chronic 
obstructive pulmonary disease is being described. Pregnancy is another risk factor for GERD. 
 
 
                       GERD is broadly classified into two categories based on the findings on 
endoscopy. They are those with oesophageal mucosal damage which include Barrett’s   
oesophagus and erosive esophagitis and those without oesophageal mucosal damage. This is 
also known as Endoscopy negative reflux disease or Non erosive reflux disease or NERD. In 
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other words, GERD can be considered as  a  spectrum of disease where NERD lies at the mild 
end of the spectrum and erosive esophagitis lies at  the other end (67).  
 
 
              The Society of American Gastrointestinal Endoscopic Surgeons (SAGES) have 
put forward the following guidelines for the diagnosis of GERD on endoscopy. These include 
presence of mucosal injury on endoscopy in patients with typical symptoms, Barrett’s 
oesophagus on biopsy, peptic stricture after excluding malignancy or a positive pH metry. But 
this criteria fails to identify patients with NERD. The severity of mucosal injury  on endoscopy 
is graded into four categories according to the Los Angeles classification (19). 
 
Grade 1- Presence of one or more mucosal breaks, none longer than 5 mm and none of which               
extends between the tops of mucosal folds.  
Grade 2- Presence of one or more mucosal breaks longer than 5 mm but none of them extends 
between the tops of mucosal folds. 
Grade 3- Presence of mucosal breaks that extends between the tops of two or more mucosal 
folds but involves less than 75 % of the oesophageal circumference. 
Grade 4- Mucosal breaks involve at least 75% of the circumference of oesophagus. 
 
                      Laryngopharyngeal reflux (LPR) is the extraesophageal variant of GERD and 
patients presents with symptoms that are different from symptoms of GERD. Most of the 
patients even deny ever having a heartburn. The usual symptoms in LPR include change in 
voice, globus sensation, chronic throat clearing, sore throat, excessive throat mucus, chronic  
cough, neck pain, voice fatigue and voice breaks etc. (31). Larynx is highly vulnerable to reflux 
as it lacks  protective mechanisms of oesophagus such as intrinsic acid clearing mechanism, 
production of bicarbonate and epithelial resistance barrier (63). Reflux is believed to damage 
 57 
 
the larynx directly and indirectly. Direct contact by acid  and pepsin with laryngeal mucosa 
results in laryngeal mucosal injury( microaspiration theory) (68). On the other hand, irritation 
of the distal oesophagus triggers a vagal response that results in chronic cough (oesophageal 
bronchial reflex theory) and recurrent throat clearing that indirectly traumatises the laryngeal 
mucosa (69).  
                                
                     LPR  has  been associated with a numerous laryngeal pathologies like muscle 
tension dysphonia, Reinke’s oedema, globus pharyngeus, posterior laryngitis, diffuse 
laryngitis, subglottic stenosis, cricoarytenoid joint ankylosis, carcinoma etc. Chung  et al (70) 
studied the significance  of  laryngopharyngeal reflux in patients with benign vocal cord lesions 
and concluded that  reflux might  play a role as an etiological factor for Reinke’s oedema and 
vocal cord polyps. They studied the presence of reflux in patients with vocal cord lesions like 
Reinke’s oedema (n=20), vocal cord polyps (n=40) and vocal cord nodules (n=50) and 
compared to a control group of LPR symptomatic patients with no signs of laryngeal lesions 
on fibreoptic laryngoscopy. They concluded that the prevalence of reflux on dual probe pH 
monitoring was more in people with laryngeal lesions.  Beltsis  et al (71)  conducted  a double 
probe pH monitoring  in patients  with benign  vocal cord pathologies  and  concluded  that  
acid reflux was  more prevalent   in   patients  with  these pathologies.                
                                     
                      Although dual probe pH monitoring is considered to be the gold standard for 
diagnosing extraesophageal reflux, it has got its own limitations. It is an invasive test as it 
requires placement of electrodes endoscopically. Also its sensitivity is not more than 75 to 
80%. Koufmann and colleagues have developed a self-administered nine item  Reflux 
Symptom Index questionnaire to assess the severity of reflux and to compare the results after 
treatment (72). The assessment can be completed in less than a minute. The scale for individual 
item varies from 0 (no problem) to 5 (severe problem) with a maximum total score of 45.  
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The questions included are 
 
1. Hoarseness or problem with your voice. 
 
2. Clearing your throat. 
 
3. Excess throat mucus or postnasal drip 
 
4. Difficulty swallowing foods, liquids or pills. 
 
5. Coughing after you ate or after lying down. 
 
6. Breathing difficulties or choking episodes. 
 
7. Troublesome or annoying cough. 
 
8. Sensations of something sticking in throat or lump in throat. 
 
9. Heartburn, chest pain, indigestion or stomach acid coming up. 
 
                 
                 
           The Reflux Finding Score is an eight item score developed by Belafsky to 
standardise the laryngeal findings in LPR to assess the clinical severity and clinical 
improvement and therapeutic efficacy after appropriate treatment. These 8 items were selected 
from a pool of most common laryngeal findings seen in LPR patients (73).The scoring is done 
by the surgeon after a laryngeal examination. 
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The scoring is as follows 
 
 
 
        1.Subglottic  oedema                                   
         
     0-absent              
       2-present 
 
 
 
        2.Ventricular obliteration 
         
       2-partial              
       4-complete 
 
 
 
        3.Vocal fold  oedema 
          
       1-mild 
       2-moderate, 
       3-severe  
       4- polypoidal 
 
        
        4. Erythema/Hyperaemia 
         
       2-arytenoids only 
       4-diffuse. 
 
 
       
 
       5.Posterior commissure hypertrophy       
   
 1-mild  
 2-moderate  
 3-severe  
 4-obstruction. 
  
 
 
       6. Diffuse Laryngeal oedema                    
     
      1-mild  
      2-moderate  
      3-severe 
      4-obstruction 
 
       
       7. Granuloma/granulation 
       
      0-absent                
      2-present. 
 
          
       8.Thick endolaryngeal mucus                
            
      0-absent               
      2-present. 
 
 
                   
 
Total Score   : 0-26.  
 
 A score of 7 indicated possible presence of laryngopharyngeal reflux. 
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                     Koufmann in 1995 first described subglottic oedema. It is also called pseudo 
sulcus vocalis. Vocal cord with pseudo sulcus is classically described as having the appearance 
of a partially open hot dog bun. The oedema is not really subglottic. Subglottic oedema extends 
from anterior commissure to posterior larynx. True sulcus or sulcus vergeture extends only up 
to the vocal process and is more in the midzone or striking zone of vocal cords whereas pseudo 
sulcus extends all the way posteriorly and is inferior to the striking zone. Presence of pseudo 
sulcus contributes 2 points to the RFS. Pseudo sulcus is also seen in aging larynx. Pseudo sulcus 
as the only finding is very rare in LPR.  
 
                            
                        Ventricular obliteration is another common finding in patients presenting with 
LPR. Ventricle is the space between true and false vocal cords. Swelling of the true cords and 
the false cords causes obliteration of the ventricular space. It is said to be partial when the 
ventricular space is reduced and the false cord edge is indistinct and complete when the true 
and false cords appear to touch each other and there is no true ventricular space. Partial 
obliteration is scored as 2 and complete obliteration is scored as 4.With effective antireflux 
treatment this finding reverses and the ventricular bands become sharp and angular 
 
            
                         Erythema or hyperaemia of larynx or posterior laryngitis is the classic finding 
described in patients presenting with reflux. Isolated erythema of arytenoids is scored as 2 
whereas diffuse erythema is scored as 4. But this is a relatively nonspecific finding as it is 
significantly dependent on the video endoscopic equipment used. Vocal fold oedema is graded 
as mild [1] if only slight swelling is present, moderate [2] if the swelling is more perceptible, 
severe [3] when the swelling of the cord becomes sessile. Polypoidal degeneration of vocal 
cord contributes 4 points to RFS.   
 
 61 
 
                        Diffuse laryngeal oedema is assessed by the size of the airway relative to the 
size of the larynx and is graded as mild, moderate, severe and obstructing. Posterior 
commissure hypertrophy is another frequent finding in LPR. It is graded as mild when there is  
moustache like appearance of posterior commissure mucosa, moderate when the mucosa is 
swollen  enough appearing like a straight line across the back of larynx, severe when there is 
bulging of posterior larynx into the airway and obstructing when a significant portion of airway 
is obliterated. Granuloma or granulation tissue and thick white endolaryngeal mucus anywhere 
in the larynx is graded as positive reflux finding.  
 
                
                      In a study conducted by Cekin et al (74), 43 patients with laryngeal pathologies 
were selected and they were evaluated for gastroesophageal reflux using the Reflux symptom 
questionnaire. They underwent microlaryngoscopy and biopsy for definitive diagnosis of the 
laryngeal pathology and the biopsy tissue was also tested for presence of H. pylori by PCR 
analysis. Reflux was found to be present in 30 out of the 43 patients and H.pylori was present 
in 18 out of 30 reflux positive patients and 6 of the 13 reflux negative patients. There was no 
statistically significant difference between reflux positivity and H. pylori status according to 
this study. 
 
 
 
Diagnosis of LPR  
 
                
 
Ambulatory pH monitoring: 
 
             
             Ambulatory 24 hour double probe pH monitoring is the investigation of choice 
for the diagnosis of laryngopharyngeal reflux. In this, the distal probe is placed 5cm above the 
lower oesophageal sphincter (LES) and the proximal probe in the hypopharynx about 1cm 
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above the upper oesophageal sphincter just behind the laryngeal inlet. The traditional technique 
was to place the probe under manometric guidance. In this, a manometer is passed through the 
nasal cavity in to the stomach. It is then slowly withdrawn and the locations of LES and UES 
are determined and the correct pH catheters are then placed based on the measurements.  
            In the modified technique, the proximal probe is placed above the upper 
oesophageal sphincter under fibreoptic guidance. The distal probe is fixed 15cm below the 
proximal probe. The percentage of time the pH is less than 4 is estimated .The measurement is 
done for the time in upright position, supine position and the total time. The upper limit of 
normal for the upright period is 8% and that for supine period is considered to be 2.5%. Any 
reflux detected by the proximal probe is considered to be LPR (75). 
 
 
Barium oesophagram: 
 
            
              This is an inexpensive and non-invasive test to diagnose the structural and 
functional abnormalities of the oesophagus. It is useful in the evaluation of oesophageal 
motility and clearance, presence of reflux and changes related to it. The sensitivity of barium 
oesophagram to detect reflux is between 20% and 60%  with a specificity of 64% to 90% (31). 
 
 
 
Oesophageal Endoscopy: 
 
                  
                     Oesophageal endoscopy provides visualisation of oesophageal mucosa and 
presence of oesophagitis, hiatal hernia, Barrett’s oesophagus etc. Endoscopy fails to identify 
patients with NERD. Ambulatory pH monitoring can pick up these candidates. 
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Radionucleide scintigraphy:  
 
                 
                     This detects the fraction of administered radioactive material refluxed into the 
oesophagus with the help of a gamma camera. This test was less sensitive compared to pH 
monitoring and barium study and hence is not routinely used (75). 
                   
 
Treatment of LPR. 
 
 
               
                 The goals of treatment are symptomatic relief, healing of esophagitis, 
prevention of complications and recurrence. 
 
 
There are 3 levels of treatment for LPR. 
 
Level I   - dietary and lifestyle modification along with antacids. 
 
Level II - Level I with use of a H2 receptor antagonist. 
 
Level III- Antireflux surgery or proton pump inhibitor therapy. 
 
 
               
                       Treatment for LPR should be individualised depending on the severity of 
patient’s symptoms. LPR patients should be advised to avoid coffee, tea, fried and spicy foods, 
alcohol etc. Patient should be advised against lying down within 2 hours of the last meal. 
Lifestyle modifications include avoidance of over eating, elevation of head end of the bed, 
quitting tobacco usage, weight reduction etc. If initial treatment with Level I and II fails, Level 
III treatment should be initiated. This include acid suppressive therapy (75). Proton pump 
inhibitors are now considered to be the most effective antireflux medications, because unlike 
H2 receptor antagonists, they produce total acid suppression. They bind to the H+ K+ ATP ase 
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and inhibits the final step in acid production. The drugs commonly used are omeprazole, 
rabeprazole, esomeprazole, lansoprazole and pantoprazole. They have a potent and constant 
effect on gastric acid secretion with minimum side effects. The recommended treatment for 
LPR is a twice daily dosing of PPI for a period of 3 to 4 months. This can be even given up to 
6 months to 1 year. Symptoms usually improve before the laryngeal findings subside. In those 
patients with delayed gastric emptying, prokinetic agents like metoclopramide and 
domperidone can be added, but they should not be used on a  long term basis because of the 
adverse effects (67).  
 
                        If there is no improvement with medications, antireflux surgery should be 
considered.  PPI effectively reduces acid reflux, but the larynx and pharynx is still exposed to 
pepsin and bile reflux. In such cases antireflux surgery can be considered. The main procedure 
is Nissen’s fundoplication which can be open or laparoscopic. In this the fundus of stomach is 
wrapped around the lower oesophageal sphincter which acts as the antireflux barrier (20). 
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MATERIAL AND METHODS 
 
                This prospective observational study was conducted in the Department of 
Otorhinolaryngology, Christian Medical College, Vellore which is a tertiary referral centre in 
Tamil Nadu. Approval of the Institutional Review Board at Christian Medical College was 
obtained in October 2013 (IRB Min No. 8449). Patients with laryngeal pathologies presenting 
to the outpatient department were briefed about the research project and requested to participate 
in the study. 
The study was commenced after the real time PCR kit to detect the presence of 
Helicobacter pylori was procured by the Microbiology Department. 
 
STUDY DESIGN 
Observational study. 
STUDY PERIOD 
December 2013 to August 2014. 
SETTING 
             The study was conducted at the Department of ENT, Departments of 
Microbiology and Pathology, Christian Medical College and Hospital, Vellore. 
 
PARTICIPANTS 
       All patients who presented to the ENT outpatient department  with complaints  
of change in voice  and  who were scheduled for microlaryngoscopic surgery were enrolled in 
the study  after obtaining an informed consent. 
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 Inclusion criteria: 
 
               
 Patients  diagnosed with laryngeal pathologies - benign or malignant , 
 
 Scheduled to undergo Microlaryngoscopy and biopsy/ excision biopsy.  
 
 Age above 18 years. 
 
 
 
  Exclusion criteria: 
 
  Patients   on treatment with  proton pump inhibitors  or H2 antagonists   or   
  antibiotics within a period of 4 weeks.  
  Patients with  recent history  of  gastrointestinal  bleeding 
 Patients who have received radiation therapy. 
  
 SAMPLE SIZE CALCULATION 
             From  literature review done, the  average  prevalence  of  Helicobacter pylori  
infection in  laryngeal  pathologies  was about  40% 
             By applying the formula,  
                               n= Z²PQ/ d²,    
 
 where   n=sample size 
             Z=95% confidence limits,    
             P=prevalence,      Q=100-P,   d=precision (10%),  
  The   required sample size was calculated to be   100 
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STATISTICAL ANALYSIS 
                 
           The qualitative variables were expressed using frequencies and percentages. 
The prevalence of Helicobacter pylori in laryngeal pathologies was calculated using 
frequencies and percentages with 95% confidence limits. Chi-square test was done on Reflux 
symptom index questionnaire with Reflux Finding Score to determine any association 
between the two.  
 
 METHODOLOGY 
                Patients attending the ENT outpatient clinic with complaints of change in 
voice fulfilling the criteria for inclusion were recruited into the study after obtaining an 
informed valid consent. A detailed history was obtained from the subjects and clinical 
evaluation of the patient was done. Information regarding the age, sex, occupation, level of 
voice use, history of belching, voice abuse, drug history and substance addictions was 
documented. Patients were categorised in to one of the following level of voice users. 
 
Level of voice use: 
    Level I        -   elite vocal performers (singers, actors) 
   Level II       -   professional voice users (teachers, lecturers, barristers) 
   Level III      - non vocal professionals (businessman, doctors, lawyers) 
   Level IV      - non vocal non professionals (housewives and farmers) 
The baseline data collected was entered in the clinical research form. 
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                    Reflux Symptom Index (RSI) questionnaire was used to assess the presence 
of reflux symptoms. The symptoms were scored on a self - rated RSI questionnaire on a 6 
point scale from 0 = no problem to 5 = severe problem. The symptoms included hoarseness, 
throat clearing, excess throat mucus or post nasal drip, swallowing difficulty, cough after 
eating, breathing difficulty, annoying cough, foreign body sensation throat, heartburn or 
chest pain. 
Koufman Reflux Symptom Index of more than 13 indicated the presence of 
laryngopharyngeal reflux. 
Presence of laryngopharyngeal reflux in these patients was assessed by the Reflux Finding 
Score (RFS) by flexible laryngoscopy (Karl Storz, Germany).The scoring was done by the 
doctors posted in the ENT Endoscopy room. 
          
                     The recruited subjects were then scheduled for a microlaryngoscopy and 
biopsy of the laryngeal lesion under general anaesthesia. 
 
 MICROLARYNGOSCOPY   
           Patient was intubated with an appropriate size endotracheal tube to maintain 
anaesthesia as well as assist the surgeon with adequate operating space. Patient was 
positioned supine on the operating table in such a way that the cervical spine is flexed and 
atlanto-occipital joint is extended. The eyes were carefully taped to prevent corneal abrasions 
and other injuries. The head was draped with sterile drapes. A tooth guard was introduced to 
protect the teeth and alveolus from the pressure of laryngoscope. The direct laryngoscope 
was then held in the left hand of the surgeon and the scope passed gently through the right 
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side of the mouth, pushing the tongue to the left and thus visualising the uvula. Once uvula 
was visualised, the laryngoscope was pressed into the tongue base which brings the tip of 
epiglottis into view. The epiglottis was lifted up with the scope and the scope advanced into 
the endolarynx following the endotracheal tube. This brought the arytenoids and false vocal 
folds into view. The scope is advanced further till it reached just above the level of vocal 
cords. With the aid of the chest suspension the laryngoscope is fixed and fine adjustments 
were made so that the lesion was well visualised. 
                       Under microscopic visualisation, biopsy was taken from the lesion and sent for 
histopathological examination. A small tissue was separately taken in eppendorf   microtubes 
for PCR analysis for H. pylori. The tubes were carried to the microbiology lab in special ice 
containers. 
 
Fig. 19 Microlaryngoscopy setting in the operating room. 
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DNA extraction 
             Biopsy samples were stored at -70°C until the DNA extraction was done. DNA 
was extracted from the biopsy homogenate using the QIAamp DNA minikit   by using the 
blood and body fluid protocol (Qiagen, Hilden, Germany) 
 
Real-Time PCR 
 
  DNA extracts from the biopsy samples were subjected to real-time PCR, which 
was performed in a step-one real time PCR (Applied bio system) using the genesig kit for 
Helicobacter pylori. The kit is provided with 2x qPCR master mix and primer/probe mix 
specific for the detection urease encoding ureA gene subunit in the bacteria. The primer and 
probe mix works on the basis of TaqMan principle. During PCR amplification, forward and 
reverse primers hybridize to the DNA/cDNA. A fluorogenic probe is included in the same 
reaction mixture which consists of a DNA probe labelled with a 5`-dye and a 3`-quencher. 
During PCR amplification, cleavage of probe occurs which results in the separation of reporter 
and quencher dye. As a result, increase in fluorescence can be detected on a range of real-time 
PCR platforms through the FAM channel. The kit is also provided with positive control to 
ensure that the primers and probes for detecting the target UreA gene in H. pylori are working 
properly.  
           For UreA detection, the 20 µl reaction mixture was prepared as follows: 10 µl 
of qPCR master mix, 1 µl of primer/probe mix, 4 µl of RNAse/DNAse free water and 5 µl of 
DNA extract with the concentration of 5ng/µl.  
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The amplification reaction was performed with the enzyme activation at 95°C for 15 mins, 
followed by 50 cycles consisting of denaturation at 95°C for 10 sec and annealing at 60°C for 
1 minute. Samples were run in duplicates and were considered positive if at least one of the 
reactions was positive.  
 
 
Fig. 20 PCR machine 
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Result interpretation 
 
                Real-time PCR for detection urease protein encoding UreA gene in 
Helicobacter pylori was done with genesig kit.  Presence or absence of the target is the endpoint 
experiments in which fluorescence data are collected after the PCR is complete. During the 
PCR, the fluorogenic probes anneal specifically to the complementary target between the 
forward and reverse primer sites on the template DNA. During extension, AmpliTaq Gold 
DNA polymerase cleaves the hybridized probes in each sample containing the target. The 
cleavage of each matched probe separates the reporter dye from the quencher dye, resulting in 
increased fluorescence by the reporter.  After PCR cycling, the StepOne™ and StepOnePlus™ 
instruments read the fluorescence generated during the PCR amplification. The fluorescent 
signals are used to determine the presence or absence of the target in each sample. The sample 
is considered to be positive for the target showing CT value of 26 ± 3 with corresponding 
sigmoid curve. Absence of target in the sample will be indicated as showing either no 
amplification curve or curve with lower CT value. 
 
Modified Giemsa staining 
                 An additional modified Giemsa staining was done on the sample sent for 
histopathological examination. 2- 4 μm thickness paraffin sections were prepared and stained 
by modified Giemsa technique. Giemsa stain was prepared by mixing 1 gram of Giemsa 
powder with 66 ml of glycerine. The mixture was then incubated at 600C for 2 hours. Once the 
temperature of the mixture drops to room temperature level, this was mixed with 66 ml of 
methanol and kept aside for one week. Buffer solution was prepared by adding 23.7 ml of 4gm 
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of sodium hydroxide diluted with 500 ml of water and 50 ml of 13.6 gm. of potassium 
dihydrogen phosphate diluted with 500 ml of water.  20 ml of this stock solution was diluted 
with water and made to 1000 ml to prepare the working buffer solution.  
Procedure: 
 Keep the slide in xylene for 15 minutes. 
 Wash with graded alcohol 
 Wash with  water 
 Add equal amounts of Giemsa stain and working buffer solution and cover the slide for 
five minutes. 
 Wash with water for 2 minutes. 
 Blot and air dry and then mount. 
The organism Helicobacter pylori will appear purple in colour on Giemsa stain.     
  
.  
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                                      RESULTS 
 
 
                     A total of 100 patients with laryngeal pathologies were enrolled in the 
study. They comprised of patients both with benign and malignant pathologies like vocal cord 
polyps, vocal cord keratosis, vocal cord papilloma, chronic laryngitis and vocal cord malignant 
pathology like carcinoma. Subjects with vocal cord polyps formed the majority of the study 
population comprising 57 %. Fig. 21 shows the distribution of the various vocal cord 
pathologies. 
 
 
 
 
 
 
Fig. 21 Distribution of laryngeal pathologies. 
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Baseline characteristics of the study population 
 
 
 
 
Age distribution: 
  
           
 
 
           The age of the patients in the study group ranged from 20 to 76 years with a mean age 
of 48 years. Majority of the patients were in the 40-60 age group. This indicates that the vocal 
cord lesions are present more frequently in the middle aged population than in the younger and 
elderly group. The age distribution of the study population is shown in Fig. 22 
 
 
 
 
Fig. 22 Age distribution of the study population. 
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Sex distribution of the study population 
 
 
 
 
    
               Of the 100 subjects, 89% (89) were males and 11 % (11) were females. The sex 
distribution of the study subjects is shown in Fig. 23 
 
 
 
 
 
 
 
 
Fig. 23 Sex distribution of the study population. 
 
         
 
                 Majority of the patients were Level 3 voice users (44%).  Level 2 voice users 
comprised 27% of study population and 29 % were Level 4 voice users. There were no Level 
1 voice users in the study. Fig. 24 shows distribution of the level of voice users. The study 
population included teachers, business men, policemen, engineers, farmers and housewives. 
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Fig. 24 Level of voice use in the study population. 
 
 
 
                            
 
                      
                The most common presenting symptom was hoarseness followed by throat clearing, 
foreign body sensation of throat and belching. Other symptoms were cough, difficulty in 
swallowing, difficulty in breathing and throat pain. The presenting symptoms of the study 
population is shown in Fig. 25 
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Fig. 25 Presenting symptoms of the study population. 
 
 
Table 1.  Presenting symptoms with the number of patients in the study. 
 
PRESENTING COMPLAINTS  NUMBER OF PATIENTS  
    
Hoarseness         
 
Throat clearing             
                                   
                   97 
59 
 
Foreign body sensation throat                                                 34  
Belching  29  
Throat pain 
 
      8  
Cough 
 
Difficulty in breathing                                                                           
 
Difficulty in swallowing 
 
Neck  swelling                               
 13 
11 
5 
0 
 
    
9
7
5
9
3
4
2
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7
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Duration of hoarseness.  
 
 
 
 
 
    
 
 
 
 
Fig. 26 Duration of hoarseness in the study population. 
 
 
                           
 
                  
                       In our study, a total of 97 patients presented with hoarseness of voice. Out of 
this 37.1 % (36 patients) had this complaint for more than 1 year duration. 
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           A total of 59 patients had history of voice abuse or voice misuse (Fig. 27). Out of this, 
45.8 % reported voice abuse-misuse for more than 10 years and 33.9% had voice abuse-misuse 
for more than 5 years (Fig. 28). Thus voice abuse-misuse seemed to play a significant role in 
patients with vocal cord disorders. 
 
 
 
 
 
 
 
 
Fig. 27 Percentage of voice abuse-misuse in the study population. 
 
 
 
59
41
present absent
 81 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28 Duration of voice abuse-misuse with the percentage of subjects in the study. 
 
 
 
 
 
Risk factors in vocal cord pathologies. 
 
 
 
              The various risk factors analysed in our study were smoking, alcohol consumption and 
tobacco chewing. 
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Fig. 29 Risk factors in the study population. 
 
 
 
 
 
             Majority of the patients smoked tobacco. The minimum duration of smoking was 2 
years and the maximum was 55 years in the study. 20 patients had the habit of both smoking 
and alcohol consumption. 
 
 
 
 
 
 
 
57
20
22
0
10
20
30
40
50
60
Smoking Alcohol consumption Tobacco chewing
P
e
rc
e
n
ta
g
e
 o
f 
s
u
b
je
c
ts
Risk factors
 83 
 
 
 
Fig. 30 Duration of smoking in the study population. 
 
 
 
           The prevalence of smokers in laryngeal cancer in our study was 80 %. Out of the 30 
patients with laryngeal cancer, 24 were smokers. Fig. 31 shows the percentage of smoking in 
laryngeal cancer. 
 
 
 
 
Fig. 31 Percentage of smokers in laryngeal cancer. 
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                 The percentage of alcohol consumption in subjects with laryngeal cancer was 20 %. 
6 of the patients with laryngeal cancer were consumers of alcohol. The percentage of alcoholics 
were less compared to that of smokers. 
 
 
 
 
 
 
 
 
 
 
Fig. 32. Percentage of alcohol consumers in laryngeal cancer. 
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DETECTION OF HELICOBACTER PYLORI 
 
 
 
PCR Analysis 
 
 
 
Table 2.    Results of Real time PCR analysis 
 
 
LARYNGEAL PATHOLOGY 
 
POSITIVE 
 
NEGATIVE 
 
Benign 
 
0 
 
100 
 
Malignant 
 
0 
 
100 
 
 
 
 
 
Giemsa Analysis 
 
 
 
Table 3. Results of histopathological examination by Giemsa Staining 
 
 
LARYNGEAL PATHOLOGY 
 
POSITIVE 
 
NEGATIVE 
 
Benign 
 
0 
 
100 
 
Malignant 
 
0 
 
100 
 
 
 
 
 
         Out of the 100 cases studied, none of them were positive for Helicobacter pylori by PCR 
analysis or Giemsa staining method. 
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Fig. 33 Results of real time PCR analysis 
 
 
 
 
 
 
                The sigmoid shaped green curve indicates the positive control.  The red coloured line 
indicated the study cases which were negative. 
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Fig. 34 Giemsa staining on vocal cord polyp 
 
 
 
 
 
Fig. 35 Giemsa staining on carcinoma larynx. 
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Laryngopharyngeal reflux and laryngeal pathology 
 
 
 
                      We also analysed the prevalence of laryngopharyngeal reflux in these subjects. 
Out of 100 patients, 21 had complaints of belching and acid reflux. The rest of the study 
subjects had complaints of foreign body sensation throat, frequent throat clearing etc. 
 
 
 
 
 
                     
 
Fig. 36 Belching in the study population 
 
 
       
 
              
               Presence of   laryngopharyngeal reflux was assessed by Reflux Symptom Index 
Questionnaire and Reflux Finding Score.  
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           Out of the total 100 patients, 14 patients had a significant RSI score. RSI score 
more than or equal to 13 was considered to be significant. Out of these 14 patients, 10 had 
vocal cord polyp and 4 had carcinoma larynx 
 
 
 
 
 
 
 
 
Fig. 37 Reflux Symptom Index in the study population. 
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                   Out of the 100 patients, 35 had a significant Reflux Finding Score. 21 of these 
patients had vocal cord polyp. Reflux Finding Score more than or equal to 7 was considered to 
be significant. 
 
 
 
 
 
 
 
 
Fig. 38 Reflux Finding Score in the study population. 
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Reflux Symptom Index versus Reflux Finding Score. 
 
 
                  On comparing RSI with RFS, it was noted that out of the 14 patients who had   
 
laryngopharyngeal reflux as per RSI, 10 (71.4%) patients also had laryngopharyngeal  
 
reflux as per RFS. 
  
 
 
 
 
Table 4. Comparison of RSI with RFS 
                                        
 
 
 
 
     Reflux Finding Score 
 
                  Reflux Symptom Index 
 
     Negative 
     
     Positive 
     
         Negative 
      
        65 
   
        4 
      
         Positive 
      
         25 
   
       10 
               
 
 
 
 
                 
The correlation between RSI and RFS was found to be statistically significant with a p value 
of .002. 
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               We also analysed the relationship between dinnertime and bedtime gap and 
significance of reflux. A gap of less than 2 hour between dinnertime and bedtime is associated 
with increased reflux. In our study, a total of 90 patients had less than 2 hour interval between 
dinner time and bedtime. Out of this 15.6% (n=14) had significant RSI and 35.6% (n=32) had 
significant RFS. Out of the 10 patients who had dinnertime and bedtime gap more than 2 hours, 
none of them had significant RSI and only 3 of them (35%) had significant RFS. 
 
 
 
 
 
 
 
 
Fig. 39 Dinnertime bedtime gap and percentage of subjects. 
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              Out of the total 57 patients with vocal cord polyps, 36.8% (n=21) had significant reflux 
finding score and in 63.2% this was not significant and the p value was not significant. 
  
 
 
Fig. 40 Vocal cord polyps and Reflux Finding Score 
 
 
            Out of the total 30 patients with carcinoma of larynx, 36.7 % (n=11) had significant 
RFS and in 63.3% (n =19) it was not significant. 
 
 
 
Fig. 41 Vocal cord carcinoma and Reflux Finding Score. 
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                                                   DISCUSSION 
         
 
                         
                            Helicobacter pylori discovered in 1982 by Barry Marshall and Robin Warren 
is a gram negative spiral shaped microaerophilic bacteria known to colonise the gastric 
epithelial cell surface. Whether the bacteria can colonise the upper aerodigestive tract in areas 
like the oral cavity, pharynx and larynx is still being studied. This prospective study was 
undertaken to study if the bacteria was present in the laryngeal pathological tissue. Also the 
association of laryngopharyngeal reflux and laryngeal pathologies was studied along with its 
association in patients in whom H. pylori was detected. Helicobacter pylori is a common 
coloniser of human gastric mucosa. It reaches the stomach which is its primary reservoir via 
the oral cavity. The transmission can be either oro-oral or faeco-oral. Whether the bacteria can 
colonise in the upper aerodigestive tract involving oral cavity, pharynx and larynx are still 
under debate. Mapestone et al (3) demonstrated the presence of  H. pylori in the dental plaque 
and saliva of patients with proven   gastric colonisation by means of nested PCR. Kusano et al 
(2) have demonstrated the presence of coccoid forms of Helicobacter pylori in the 
tonsillectomy specimens of patients with Ig A nephropathy by means of immunofluorescence 
and immunoelectron microscopy, however they could not culture the bacteria . 
 
                            Pajic´-Penavic´ et al (4) studied normal laryngeal tissue for the presence of 
H. pylori and concluded that it was not a commensal there. Recently various studies were 
carried out to determine whether this bacterium could be responsible for pathogenesis of 
laryngeal diseases and whether the eradication of the bacteria would help in the treatment of 
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the same. Larynx, an area of upper aerodigestive tract is a potential area that could be exposed 
to the gastric contents by means of reflux. Since Helicobacter pylori infection is an established 
aetiological agent for chronic gastritis and gastric cancer, it could be postulated that the 
organism might play a role in the pathogenesis of laryngeal disease in general and laryngeal 
cancer in particular. Helicobacter pylori is the first bacterium to be labelled as a definite 
carcinogen for gastric cancer and mucosa associated lymphoma of the stomach by the World 
Health Organisation (26). 
 
               Studies have been conducted to determine the role of Helicobacter pylori in 
laryngeal diseases. Akbayir et al (76) studied the presence of H. pylori in 50 patients  of 
laryngeal cancer who underwent  total or partial laryngectomy and  in 50 patients with benign 
laryngeal pathologies by histopathological and immunohistochemical methods, but none of 
them were positive for H. pylori. Masoud et al (77)  investigated the role of H. pylori in 44 
patients with squamous cell carcinoma of larynx and 30 patients with benign laryngeal lesions 
like polyp, nodule and granuloma by means of rapid urease testing and routine 
histopathological examination. None of the tests could detect H. pylori in any of these 
specimens. They concluded that H. pylori is unlikely to colonise larynx and that larynx is not 
a permanent reservoir for this bacterium. Our study used the most specific method of detection, 
i.e. real time PCR and did not detect the presence of bacterium in any of the benign or malignant 
laryngeal lesions.  
 
                                
                       Some studies have shown a positive association of Helicobacter pylori in 
laryngeal pathologies. Fellman  et al (7) studied the presence of  H. pylori in the upper 
aerodigestive tract of patients with proven gastric colonisation and established their presence 
in the larynx, pharynx and oral cavity by means of PCR analysis. They concluded that the upper 
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aerodigestive tract can be an additional reservoir for this bacterium in patients with H. pylori 
gastritis. Rubin et al (78) and Borowski et al  (79) noted a positive association  between  H.  
pylori and  chronic laryngitis whereas Jaspersen  et al (80) proved a negative association. Rubin 
et al tested for the presence of serum antibodies for H. pylori in patients with laryngeal lesions 
whereas Borowski et al and Jaspersen et al performed rapid urease testing for detecting the 
bacteria. Also  Ozyurt et al (26) detected H. pylori DNA  in laryngeal pathologies, nasal mucosa 
and nasal polyps by real time PCR method.  A similar study was conducted by Siupsinskiene 
et al (81) to detect the presence of H. pylori in patients suffering from benign laryngeal diseases 
and laryngeal cancer. They performed rapid urease testing and histopathological examination 
of the laryngeal specimen by modified Giemsa technique for identification of the bacterium 
and could identify the bacterium in 45.5% of patients with chronic laryngitis and 46.2% of 
patients with laryngeal cancer. They concluded that H. pylori infection could be a possible risk 
factor for laryngeal pathologies. Cekin et al (74) also studied the association of Helicobacter 
pylori and laryngopharyngeal reflux in patients with laryngeal pathologies. They performed 
real time PCR to detect UreC gene in H. pylori and the presence of laryngopharyngeal reflux 
was assessed by Reflux Symptom Index and Reflux Finding Score similar to our study. They 
could detect H. pylori in 55.8% of subjects with laryngeal pathologies. 69.8% of subjects had 
significant Reflux Finding Score, but they could not find a significant association between 
reflux and H. pylori positivity.      
                 
                   In our study we used the Genesig kit which detects the target ureA gene in H. 
pylori. The targets routinely used to detect H. pylori by PCR methods include the 16S rRNA 
gene, the random chromosome sequence, the 26-kDa species-specific antigen (SSA) genes, the 
urease (ureA) gene and the glmM (ureC) gene. Espinoza et al (82) compared the efficacy of 
ureA gene and ureC  gene in detecting H. pylori by PCR method and concluded that PCR assay 
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using ureC gene could detect all those strains which were  not picked up by ureA analysis. The 
ureC gene is a house keeping gene which directly participates in the cell wall synthesis of the 
bacteria and is unrelated to urease production unlike the ureA gene. Another study conducted 
by Smith et al (83) to evaluate the most appropriate method of PCR to detect H. pylori showed 
that detection using ureA gene had poor specificity and that using 26 kDa was the best method. 
Since our study used only one target to detect H. pylori we could have possibly missed out the 
organism by PCR analysis. 
 
                        Giemsa staining could not detect any Helicobacter pylori in both benign and 
malignant lesions in our study. This can be explained by a probable low bacterial load in the 
larynx. In such cases Giemsa staining has less sensitivity to detect the organism. Also it is said 
that multiple biopsies from different sites increases the chance of detecting the organism which 
was not possible in our study since most of the laryngeal lesions were only few millimetres in 
size. H. pylori in biopsy slides appear as a comma shaped or S- shaped bacillus 2.5- 4 μm long 
and 0.5- 1 μm thick. Even for detection of the bacteria in the gastric antrum, a good quality 
biopsy specimen with adequate epithelial cells are necessary and it is difficult to draw a 
conclusion when the bacterial load is very low with altered morphology (84). In one another 
study, Aslan et al (85) demonstrated the presence of  H. pylori in tonsillar specimen by 
PontoDry test but failed to demonstrate it in the histopathological specimen by haematoxylin-
eosin, Giemsa or Warthin Starry silver staining technique. 
 
 
               
                       In our study of total 100 patients, a definite male preponderance was seen. 89 % 
of the study population consisted of men. This is in favour of male predominance seen in vocal 
cord pathologies as described by various other studies. Banjara et al (86) analysed the 
demographic characteristics of  various vocal cord pathologies and concluded  that  most of 
 98 
 
them occurred in male population. Majority of the patients in the study belonged to the middle 
aged group. Also laryngeal cancers showed a definite male preponderance as proven by 
previous studies (87). This is because men used to smoke more and consume alcohol more than 
women. In our study, out of 30 patients with laryngeal cancer, 28 were males. 
 
 
           
 
                        The various risk factors analysed in our study were smoking, alcohol 
consumption and tobacco chewing. Smoking was reported in 58% of the study population and 
is regarded as one of the major risk factors for vocal cord lesions, especially malignancies of 
the vocal cord. Out of the 30 patients with carcinoma of larynx, 24 had history of smoking. 
Thus the prevalence of smoking in carcinoma in our study was 80 %. This was in keeping with 
various other studies described in literature (88,89). Larynx is more susceptible to the harmful 
effects of smoking as compared to other areas in head and neck. This can be explained by the 
aerodynamics of the respiratory airflow as the airflow becomes more turbulent in larynx   
resulting in higher exposure to the inhaled carcinogens. Alcohol consumption did not show a 
significant role in laryngeal cancers in our study. The prevalence of alcohol consumption in 
patients with laryngeal cancer was only 20%. 
 
 
                        Vocal abuse or voice misuse is another risk factor for vocal cord pathologies. 
Hoarseness was the predominant symptom in the study group. Out of 100 patients, 97 presented 
with change in voice.  Voice abuse leads to phono trauma and is the most important factor 
underlying the development of benign vocal cord pathologies. Phonotrauma refers to the 
physical stress on the tissues of vocal fold that occur during phonation (90). Phonotrauma 
depends on the amount and intensity of voice use. In our study, 59% of the population had 
history of voice abuse and among them majority (88.9%) presented with vocal cord polyps. 
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                       Laryngopharyngeal reflux is a common diagnosis made by otolaryngologists in 
patients presenting with hoarseness. LPR manifests in a wide variety of symptoms as globus 
pharyngeus, hoarseness, sore throat, dysphagia, throat clearing or chronic cough. So it is very 
important to make an accurate diagnosis. Double probe pH manometry is cumbersome to be 
performed in every patients who presents with symptoms of reflux because it is invasive and 
costly. To overcome this difficulty endoscopic examination of laryngopharynx for signs of 
reflux by Reflux Finding Score was introduced by Belafsky. 
 
                       Laryngeal mucosa is poorly suited to resist the components of reflux as 
compared to oesophageal mucosa. As many as fifty reflux episodes in a day is considered to 
be physiological in oesophagus whereas a single episode of reflux into the laryngopharynx is 
detrimental. Pepsin in the refluxate is believed to damage the cell membrane integrity by 
disrupting the intercellular junction complex and increasing the intercellular space. Also acid 
remains in contact with the mucosa for a prolonged period of time due to lack of peristalsis in 
the larynx as compared to oesophagus. Since the laryngeal mucosa does not come in contact 
with saliva normally, the acid neutralisation power of salivary bicarbonate is also not effective. 
The mucosal damage once occurred takes at least six months to heal. If the inflammation goes 
on the symptoms increases and the severity of mucosal damage increases (91). 
 
                        We also analysed the presence of reflux by means of Reflux Symptom Index 
and Reflux Finding Score. In our study, a total of 35 patients had significant reflux finding 
score and 14 patients had significant Reflux Symptom Index. Congested arytenoids was the 
most common finding observed followed by posterior commissure hypertrophy.  In a study 
conducted by Koufman et al (92) the prevalence of reflux in patients with laryngeal disorders 
was assessed by double probe pH monitoring and was estimated to be around 50% in the study 
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population. They concluded that reflux plays a significant role in patients with laryngeal 
pathologies. In our study, out of the total 57 patients with vocal cord polyps, 36.8% (n=21) had 
significant reflux finding score. Our study also found an association between reflux and vocal 
fold polyps but this was not statistically significant. 
 
 
               
                 The association of laryngopharyngeal reflux in laryngeal cancer is widely being 
studied, but is the association causal is yet unclear. In the last few years reflux has been studied 
as an independent carcinogen as well as a cocarcinogen along with smoking and alcohol 
consumption in laryngeal cancer. Copper et al (93) performed double probe pH monitoring in 
24 patients  with squamous cell carcinoma of larynx and pharynx and concluded that 16 of 
these patients had pathological reflux. Refluxed acid and bile irritates the laryngeal mucosa 
leading to chronic laryngitis and in the long run to laryngeal carcinoma. We studied the 
significance of reflux in patients with laryngeal cancer by Reflux finding score and found out 
that 11 (36.7%) out of 30 patients had reflux which was not statistically significant. 
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                               LIMITATIONS 
 
                                
 
                              
                        Our study was also not free from limitations. We used the Genesig kit for 
detecting UreA gene in H. pylori by real time PCR method. 
              The amount of DNA in the test specimen was variable. The DNA tested was not 
pure bacterial DNA. Since the sample tested was a tissue specimen, it had a mixture of host 
DNA with the bacterial DNA. Hence the amount of bacterial DNA if present might have been 
very minimal or might not be present in the sample tested. Since laryngeal biopsy specimens 
are very small, the presence of bacteria in the sample tested is questionable.  
               For effective detection of DNA template by PCR, the minimum amount of DNA 
required is about 10-20ng/μl. At least 5ng of DNA template is required for effective detection 
as per the kit instruction. DNA present below the estimated threshold hinders the detection of 
target. Only few samples in our study had this required nucleic acid concentration. Also the 
RNA to DNA ratio in the samples analysed were not showing convincing values. Thus the 
amount of sample available and the methods of DNA extraction is a definite limitation of our 
study. 
                Another limitation of our study was determination of Reflux Finding Score. 
This was a very subjective study and was done by different doctors in the endoscopy room. So 
we might have missed out some patients who really had reflux. 
                One of our exclusion criteria was that the patient should not be on any proton 
pump inhibitors for at least a period of 4 weeks. Since this a very common drug taken by 
people, some of them might have actually taken this medication and were not aware of the 
same. 
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                                CONCLUSION 
 
 
 
                    In this study conducted on 100 patients with hoarseness and laryngeal 
pathologies, Helicobacter pylori was not isolated in the laryngeal tissue biopsy material 
suggesting that the organism had no role in the development of benign or malignant laryngeal 
pathology. PCR test using primers which can detect all the genes (UreA, glmM, 26kDa SSA, 
16S rRNA) in H. pylori would be more specific than detecting a single gene which might 
possibly be missed during testing.  
               Our study also found an association between laryngopharyngeal reflux in 
laryngeal pathologies, even though the association did not reach statistical significance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 103 
 
                            
                              BIBLIOGRAPHY 
 
 
         
1.  Franceschi F, Gasbarrini A. Helicobacter pylori and extragastric diseases. Best Pract Res 
Clin Gastroenterol. 2007;21(2):325–34.  
2.  Kusano K, Inokuchi A, Fujimoto K, Miyamoto H, Tokunaga O, Kuratomi Y, et al. 
Coccoid Helicobacter pylori exists in the palatine tonsils of patients with IgA 
nephropathy. J Gastroenterol. 2010 Apr;45(4):406–12.  
3.  Mapstone NP, Lynch DA, Lewis FA, Axon AT, Tompkins DS, Dixon MF, et al. 
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with 
gastritis using PCR. J Clin Pathol. 1993 Jun;46(6):540–3.  
4.  Pajić-Penavić I, Danić D, Maslovara S, Gall-Trošelj K. Absence of Helicobacter pylori in 
healthy laryngeal mucosa. J Laryngol Otol. 2012 Feb;126(2):196–9.  
5.  Pirzadeh A, Doustmohammadian N, Khoshbaten M, Doustmohammadion S. Is there any 
association between Helicobacter Pylori infection and laryngeal carcinoma? Asian Pac J 
Cancer Prev. 2011;12(4):897–900.  
6.  Pilotto A, Franceschi M. Helicobacter pylori infection in older people. World J. 
Gastroenterol. 2014 Jun 7;20(21):6364–73.  
7.  Fellmann J, Weisert JU, Soltermann A, Morand G, Morra L, Moch H, et al. Helicobacter 
pylori detected in pharyngeal and laryngeal pathologies in patients with proven gastric 
colonization. Head Neck. 2013 Aug 30;  
8.  Saki N, Samarbaf Zadeh AR, Sheikhpour Jonaky R, Noori SM, Kayedani GA, 
Nikakhlagh S. The Prevalence Rate of Helicobacter pylori Infection in, Chronic Otitis 
Media With Effusion Patients. Jundishapur J Microbiol. 2014 Mar;7(3):e15694.  
9.  Medical Microbiology, 18th Edition | David Greenwood, Richard Slack, Michael Barer, 
Will Irving | ISBN 9780702040894 [Internet]. [cited 2013 Dec 12]. Available from: 
http://store.elsevier.com/Medical-Microbiology/isbn-9780702040894 
 104 
 
10.  Zanotti G, Cendron L. Structural and functional aspects of the Helicobacter pylori 
secretome. World J. Gastroenterol. 2014 Feb 14;20(6):1402–23.  
11.  Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of 
expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori 
reveals that clinical isolates can be divided into two major types and that CagA is not 
necessary for expression of the vacuolating cytotoxin. Infect Immun. 1995 Jan;63(1):94–
8.  
12.  Chambers MG, Pyburn TM, Gonzalez-Rivera C, Collier SE, Eli I, Yip CK, et al. 
Structural Analysis of the Oligomeric States of Helicobacter pylori VacA Toxin. J Mol 
Biol. 2013 Feb 8;425(3):524–35.  
13.  Fang T-J, Lee L-A, Li H-Y, Yang C, Huang C-G. Helicobacter pylori colonization in the 
larynges of patients with hoarseness. The Laryngoscope. 2008 Mar;118(3):389–93.  
14.  Wang XM, Yee KC, Hazeki-Taylor N, Li J, Fu HY, Huang ML, et al. Oral Helicobacter 
pylori, its relationship to successful eradication of gastric H. pylori and saliva culture 
confirmation. J Physiol Pharmacol. 2014 Aug;65(4):559–66.  
15.  Vaishnavi C. Infections of the Gastrointestinal System. 1 edition. New Delhi: Jp Medical 
Ltd; 2013. 621 p.  
16.  Hagymasi K, Tulassay Z. Helicobacter pylori infection: New pathogenetic and clinical 
aspects. World J. Gastroenterol . 2014 Jun 7;20(21):6386–99.  
17.  Souza RCA de, Lima JHC. Helicobacter pylori and gastroesophageal reflux disease: a 
review of this intriguing relationship. Dis Esophagus. 2009;22(3):256–63.  
18.  Ghoshal UC, Chourasia D. Gastroesophageal Reflux Disease and Helicobacter pylori: 
What May Be the Relationship? J Neurogastroenterol Motil. 2010 Jul;16(3):243–50.  
19.  Polat FR, Polat S. The effect of Helicobacter pylori on gastroesophageal reflux disease. 
JSLS. 2012 Jun;16(2):260–3.  
20.  Yılmaz T, Bajin MD, Günaydın RÖ, Ozer S, Sözen T. Laryngopharyngeal reflux and 
Helicobacter pylori. World J. Gastroenterol. 2014 Jul 21;20(27):8964–70.  
 105 
 
21.  Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. 
Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. 
Am J Gastroenterol. 1998 Dec;93(12):2330–8.  
22.  Hahn M, Fennerty MB, Corless CL, Magaret N, Lieberman DA, Faigel DO. Noninvasive 
tests as a substitute for histology in the diagnosis of Helicobacter pylori infection. 
Gastrointest Endosc. 2000 Jul;52(1):20–6.  
23.  Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF. Histological identification of 
Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000 
Oct;53(10):756–9.  
24.  Real Time PCR Handbook [Internet]. [cited 2014 Jun 24]. Available from: 
http://www.lifetechnologies.com/in/en/home/life-science/pcr/real-time-pcr/qpcr-
education/real-time-pcr-handbook.html?cid=rtpcrhandbook-rtpcr 
25.  Titiz A, Ozcakir O, Ceyhan S, Yilmaz YF, Unal A, Akyon Y. The presence of 
Helicobacter pylori in the larynx pathologies. Auris Nasus Larynx. 2008 Dec;35(4):534–
8.  
26.  Ozyurt M, Gungor A, Ergunay K, Cekin E, Erkul E, Haznedaroglu T. Real-time PCR 
detection of Helicobacter pylori and virulence-associated cagA in nasal polyps and 
laryngeal disorders. Otolaryngol--Head Neck Surg. 2009 Jul;141(1):131–5.  
27.  Molina-Infante J, Gisbert JP. Optimizing clarithromycin-containing therapy for 
Helicobacter pylori in the era of antibiotic resistance. World J Gastroenterol WJG. 2014 
Aug 14;20(30):10338–47.  
28.  Gisbert JP, Calvet X. Update on non-bismuth quadruple (concomitant) therapy for 
eradication of Helicobacter pylori. Clin Exp Gastroenterol. 2012;5:23–34.  
29.  Gleeson MJ, Clarke RC. Scott-Brown’s Otorhinolaryngology: Head and Neck Surgery. 7 
edition. London: CRC Press; 2008: 2130-39, 2192-204 
30.  Huang BY, Solle M, Weissler MC. Larynx: Anatomic Imaging for Diagnosis and 
Management. Otolaryngol Clin North Am. 2012 Dec;45(6):1325–61.  
 106 
 
31.  Flint PW,  Haughey BH, Lund VJ, Niparko JK, Richardson MA. Cummings 
Otolaryngology - Head and Neck Surgery,5 edition. Philadelphia: Mosby; 2010. 894-901, 
1482-88.  
32.  Armstrong WB, Netterville JL. Anatomy of the larynx, trachea, and bronchi. Otolaryngol 
Clin North Am. 1995 Aug;28(4):685–99.  
33.  Sataloff RT, Heman-Ackah YD, Hawkshaw MJ. Clinical Anatomy and Physiology of the 
Voice. Otolaryngol Clin North Am. 2007 Oct;40(5):909–29.  
34.  Noordzij JP, Ossoff RH. Anatomy and Physiology of the Larynx. Otolaryngol Clin North 
Am. 2006 Feb;39(1):1–10.  
35.  Robbins KT. Classification of neck dissection: current concepts and future 
considerations. Otolaryngol Clin North Am. 1998 Aug;31(4):639–55.  
36.  Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, et al. Neck 
dissection classification update: revisions proposed by the American Head and Neck 
Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch 
Otolaryngol Head Neck Surg. 2002 Jul;128(7):751–8.  
37.  Robbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito A, et al. Consensus 
statement on the classification and terminology of neck dissection. Arch Otolaryngol 
Head Neck Surg. 2008 May;134(5):536–8.  
38.  Altman KW. Vocal Fold Masses. Otolaryngol Clin North Am. 2007 Oct;40(5):1091–108.  
39.  Rosen CA, Gartner-Schmidt J, Hathaway B, Simpson CB, Postma GN, Courey M, et al. 
A nomenclature paradigm for benign midmembranous vocal fold lesions. The 
Laryngoscope. 2012 Jun;122(6):1335–41.  
40.  Singhal P, Bhandari A, Chouhan M, Sharma MP, Sharma S. Benign tumors of the larynx: 
a clinical study of 50 cases. Indian J Otolaryngol Head Neck Surg . 2009 Jan;61(Suppl 
1):26–30.  
41.  Nunes RB, Behlau M, Nunes MB, Paulino JG. Clinical diagnosis and histological 
analysis of vocal nodules and polyps. Braz J Otorhinolaryngol. 2013 Aug;79(4):434–40.  
 107 
 
42.  Borkowski G, Sommer P, Stark T, Sudhoff H, Luckhaupt H. Recurrent respiratory 
papillomatosis associated with gastroesophageal reflux disease in children. Eur Arch Oto-
Rhino-Laryngol. 1999;256(7):370–2.  
43.  Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. The 
Laryngoscope. 2008 Jul;118(7):1236–47.  
44.  Goswami S, Patra TK. A Clinico-pathological study of Reinke’S oedema. Indian J 
Otolaryngol Head Neck Surg. 2003 Jul;55(3):160–5.  
45.  Bartlett RS, Heckman WW, Isenberg J, Thibeault SL, Dailey SH. Genetic 
characterization of vocal fold lesions: leukoplakia and carcinoma. The Laryngoscope. 
2012 Feb;122(2):336–42.  
46.  Martins RHG, Dias NH, Santos DCD, Fabro AT, Braz JRC. Clinical, histological and 
electron microscopic aspects of vocal fold granulomas. Braz J Otorhinolaryngol. 2009 
Feb;75(1):116–22.  
47.  Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related 
lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978 
Oct;46(4):518–39.  
48.  Sadri M, McMahon J, Parker A. Management of laryngeal dysplasia: a review. Eur Arch 
OtoRhinoLaryngol. 2006 Sep;263(9):843–52.  
49.  Williamson JS, Biggs TC, Ingrams D. Laryngeal cancer: an overview. Trends Urol Mens 
Health. 2012 Nov 1;3(6):14–7.  
50.  Merletti F, Boffetta P, Ciccone G, Mashberg A, Terracini B. Role of tobacco and 
alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, 
Italy. Cancer Res. 1989 Sep 1;49(17):4919–24.  
51.  Markou K, Christoforidou A, Karasmanis I, Tsiropoulos G, Triaridis S, Constantinidis I, 
et al. Laryngeal cancer: epidemiological data from Νorthern Greece and review of the 
literature. Hippokratia. 2013 Oct;17(4):313–8.  
 108 
 
52.  Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, Toohill RJ. Carcinoma of 
the larynx in patients with gastroesophageal reflux. Am J Otolaryngol. 1996 
Dec;17(6):386–90.  
53.  Francis DO, Maynard C, Weymuller EA, Reiber G, Merati AL, Yueh B. Reevaluation of 
gastroesophageal reflux disease as a risk factor for laryngeal cancer. The Laryngoscope. 
2011 Jan;121(1):102–5.  
54.  Johnston N, Yan JC, Hoekzema CR, Samuels TL, Stoner GD, Blumin JH, et al. Pepsin 
promotes proliferation of laryngeal and pharyngeal epithelial cells. The Laryngoscope. 
2012 Jun;122(6):1317–25.  
55.  Boffetta P, Richiardi L, Berrino F, Estève J, Pisani P, Crosignani P, et al. Occupation and 
larynx and hypopharynx cancer: an international case-control study in France, Italy, 
Spain, and Switzerland. Cancer Causes Control. 2003 Apr;14(3):203–12.  
56.  Agudelo D, Quer M, León X, Díez S, Burgués J. Laryngeal carcinoma in patients without 
a history of tobacco and alcohol use. Head Neck. 1997 May;19(3):200–4.  
57.  Genç R, Çağlı S, Yüce İ, Vural A, Okuducu H, Patıroğlu T, et al. The role of H. pylori in 
the development of laryngeal squamous cell carcinoma. Dis Markers. 2013;35(5):447–9.  
58.  Rezaii J, Tavakoli H, Esfandiari K, Ashegh H, Hasibi M, Ghanei G, et al. Association 
between Helicobacter pylori infection and laryngohypopharyngeal carcinoma: A case–
control study and review of the literature. Head Neck. 2008 Dec 1;30(12):1624–7.  
59.  Califano J, Riet P van der, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic 
Progression Model for Head and Neck Cancer: Implications for Field Cancerization. 
Cancer Res. 1996 Jun 1;56(11):2488–92.  
60.  Chu EA, Kim YJ. Laryngeal Cancer: Diagnosis and Preoperative Work-up. Otolaryngol 
Clin North Am. 2008 Aug;41(4):673–95.  
61.  Agrawal N, Ha PK. Management of early-stage laryngeal cancer. Otolaryngol Clin North 
Am. 2008 Aug;41(4):757–69, vi – vii.  
62.  Ulualp SO, Toohill RJ. Laryngopharyngeal reflux: state of the art diagnosis and 
treatment. Otolaryngol Clin North Am. 2000 Aug;33(4):785–802.  
 109 
 
63.  Patel D, Vaezi MF. Normal esophageal physiology and laryngopharyngeal reflux. 
Otolaryngol Clin North Am. 2013 Dec;46(6):1023–41.  
64.  Cunningham ET, Sawchenko PE. Central neural control of esophageal motility: a review. 
Dysphagia. 1990;5(1):35–51.  
65.  Bassotti G, Bacci G, Biagini D, David P, Alunni G, Pelli MA, et al. Manometric 
investigation of the entire esophagus in healthy subjects and patients with high-amplitude 
peristaltic contractions. Dysphagia. 1988;3(2):93–6.  
66.  Kahrilas PJ. GERD pathogenesis, pathophysiology, and clinical manifestations. Cleve 
Clin J Med. 2003 Nov;70 Suppl 5:S4–19.  
67.  Nwokediuko SC. Current trends in the management of gastroesophageal reflux disease: a 
review. ISRN Gastroenterol. 2012;2012:391631.  
68.  Cherry J, Margulies SI. Contact ulcer of the larynx. The Laryngoscope. 1968 
Nov;78(11):1937–40.  
69.  Wright RA, Miller SA, Corsello BF. Acid-induced esophagobronchial-cardiac reflexes in 
humans. Gastroenterology. 1990 Jul;99(1):71–3.  
70.  Chung JH, Tae K, Lee YS, Jeong JH, Cho SH, Kim KR, et al. The significance of 
laryngopharyngeal reflux in benign vocal mucosal lesions. Otolaryngol--Head Neck 
Surg. 2009 Sep;141(3):369–73.  
71.  Beltsis A, Katsinelos P, Kountouras J, Kamarianis N, Zavos C, Pournaras A, et al. 
Double probe pH-monitoring findings in patients with benign lesions of the true vocal 
folds: comparison with typical GERD and the effect of smoking. Eur Arch 
OtoRhinoLaryngol. 2011 Aug;268(8):1169–74.  
72.  Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding 
score (RFS). The Laryngoscope. 2001 Aug;111(8):1313–7.  
73.  Belafsky PC, Postma GN, Amin MR, Koufman JA. Symptoms and findings of 
laryngopharyngeal reflux. Ear Nose Throat J. 2002 Sep;81(9 Suppl 2):10–3.  
 110 
 
74.  Cekin E, Ozyurt M, Erkul E, Ergunay K, Cincik H, Kapucu B, et al. The association 
between Helicobacter pylori and laryngopharyngeal reflux in laryngeal pathologies. Ear 
Nose Throat J. 2012 Mar;91(3):E6–9.  
75.  Snow JB, Wackym PA, Ballenger JJ. Ballenger’s Otorhinolaryngology: Head and Neck 
Surgery. PMPH-USA; 2009. 1258 p.  
76.  Akbayir N, Başak T, Seven H, Sungun A, Erdem L. Investigation of Helicobacter pylori 
colonization in laryngeal neoplasia. Eur Arch OtoRhinoLaryngol. 2005 Mar;262(3):170–
2.  
77.  Masoud N, Manouchehr K, Najmeh D, Monireh H. Lack of association between 
Helicobacter pylori and laryngeal carcinoma. Asian Pac J Cancer Prev. 2008 
Mar;9(1):81–2.  
78.  Rubin JS, Benjamin E, Prior A, Lavy J, Ratcliffe P. The prevalence of Helicobacter 
pylori infection in benign laryngeal disorders. J Voice. 2002 Mar;16(1):87–91.  
79.  Borkowski G, Sudhoff H, Koslowski F, Hackstedt G, Radü HJ, Luckhaupt H. A possible 
role of Helicobacter pylori infection in the etiology of chronic laryngitis. Eur Arch 
OtoRhinoLaryngol. 1997;254(9-10):481–2.  
80.  Jaspersen D, Weber R, Diehl KL, Kind M, Arps H, Draf W. [Is chronic laryngitis 
associated with Helicobacter pylori? Results of a prospective study]. Z Gastroenterol. 
1998 May;36(5):369–72.  
81. Siupsinskiene N, Jurgutaviciute V, Katutiene I, Janciauskas D, Vaitkus S, Adamonis K.  
      Helicobacter pylori infection in laryngeal diseases. Eur Arch OtoRhinoLaryngol. 2013  
      Aug;270(8):2283–8. 
82.  Espinoza MGC, Vazquez RG, Mendez IM, Vargas CR, Cerezo SG. Detection of the 
glmM gene in Helicobacter pylori isolates with a novel primer by PCR. J Clin Microbiol. 
2011 Apr;49(4):1650–2.  
83.  Smith S-I, Oyedeji K-S, Arigbabu A-O, Cantet F, Megraud F, Ojo O-O, et al. 
Comparison of three PCR methods for detection of Helicobacter pylori DNA and 
 111 
 
detection of cagA gene in gastric biopsy specimens. World J. Gastroenterol. 2004 Jul 
1;10(13):1958–60.  
84.  Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility 
testing. Clin Microbiol Rev. 2007 Apr;20(2):280–322.  
85.  Aslan S, Yilmaz I, Bal N, Sener M, Butros R, Demirhan B, et al. Investigation of 
Helicobacter pylori in tonsillary tissue with Pronto Dry test and pathologic examination. 
Auris Nasus Larynx. 2007 Sep;34(3):339–42.  
86.  Banjara H, Mungutwar V, Singh D, Gupta A, Singh S. Demographic and 
videostroboscopic assessment of vocal pathologies. Indian J Otolaryngol Head Neck 
Surg. 2012 Jun;64(2):150–7.  
87.  Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, et al. Cancer of the larynx. 
Crit Rev Oncol Hematol. 2003 Jul;47(1):65–80.  
88.  Maasland DHE, van den Brandt PA, Kremer B, Goldbohm RAS, Schouten LJ. Alcohol 
consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results 
from the Netherlands Cohort Study. BMC Cancer. 2014;14:187.  
89.  Menach OP, Patel A, Oburra HO. Demography and histologic pattern of laryngeal 
squamous cell carcinoma in kenya. Int J Otolaryngol. 2014;2014:507189.  
90.  Sulica L. Laryngoscopy, Stroboscopy and Other Tools for the Evaluation of Voice 
Disorders. Otolaryngol Clin North Am. 2013 Feb;46(1):21–30.  
91.  Lipan MJ, Reidenberg JS, Laitman JT. Anatomy of reflux: a growing health problem 
affecting structures of the head and neck. Anat Rec B New Anat. 2006 Nov;289(6):261–
70.  
92.  Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with 
laryngeal and voice disorders. Otolaryngol Head Neck Surg. 2000 Oct;123(4):385–8.  
93.  Copper MP, Smit CF, Stanojcic LD, Devriese PP, Schouwenburg PF, Mathus-Vliegen 
LM. High incidence of laryngopharyngeal reflux in patients with head and neck cancer. 
The Laryngoscope. 2000 Jun;110(6):1007–11. 
 i 
 
 
   
               PATIENT INFORMATION SHEET 
 
 
You are requested  to participate in this study  which   aims at  finding the  presence  of  a  
bacteria  named Helicobacter pylori  in  voice box  diseases. In this study you will be asked 
details of your disease in the form of a questionnaire. An endoscopic visualization of your   
voice box will be done to assess your disease and also if there is an acidity problem in your 
voice box. After  obtaining  a  written consent ,you  will  undergo a microscope  assisted  
visualization of    voice box  under anaesthesia and  tissue will be taken  for biopsy. A  part  
of the tissue will be taken for the study  and  sent  for  a test  called PCR  analysis  which 
detects  the  bacteria. There would not be any risk to you by participating in this study. You 
need not pay any extra charges for the test.  You can withdraw from the study at any moment 
you feel so and this in no way will compromise your treatment. Your participation   in the 
study will remain confidential and shall be known only to investigators.  
 
 
 
 
 
 
 
 ii 
 
                 INFORMED VALID CONSENT 
 
Study number- 
Hospital number- 
Participant’s name- 
Date of birth/age                                                   
 
I,                                                 son/daughter/wife of                              have been explained 
in my own language about the proposed study. It  has been explained  that this  study  involves 
taking tissue from the lesion on  my  voice box  for testing the presence of a bacteria            (H. 
pylori) during  microlaryngoscopic biopsy under GA . This is an operation routinely done for 
patients diagnosed with my disease (clinically diagnosed laryngeal cancers/ vocal cord polyp/ 
papilloma / cyst/ nodule).It has been explained to me that there is no additional risk in the 
study and that I am free to withdraw from the study any time I want and it will not in any 
way compromise the treatment, the ENT doctors are giving me. I understand that my identity 
and participation will not be revealed in any information released to third parties. I am giving 
this consent on my own free will. I hereby give my full valid consent for participating in the 
proposed study. 
 
Name of patient                                    
Signature                                                                                   Name of   Doctor 
Date                                                                                           Signature 
                                                                                                   Date 
Name of witness 
Signature. 
Date 
 
 iii 
 
 
 
 
 
 
 iv 
 
 
 
 
 v 
 
 
 vi 
 
 
 
 
 vii 
 
                             CLINICAL RESEARCH FORM 
 
Serial no: 
Hospital no: 
Name of patient:                
Age:                                                         Sex: 
Address: 
 
Occupation: 
Level of voice use: 
Telephone number: 
Email: 
 
Presenting Complaint 
 
                                                                              Yes/ No            Duration 
Hoarseness 
Throat pain 
Difficulty in swallowing 
(Solids/ liquids/ pills) 
Foreign body sensation throat 
Cough 
Difficulty in breathing 
History of voice abuse 
History of belching/ retrosternal burning 
Throat clearing 
Neck swelling 
 viii 
 
 
Past History 
                                                                Yes/ No 
Diabetes 
Hypertension 
Tuberculosis 
Bronchial asthma 
Others 
 
Drug History                             
                                                                                                       Yes/ No 
Proton pump inhibitors (within 4 weeks) 
H2 antagonists (within 4 weeks) 
Antibiotics (within 4 weeks) 
Others 
 
Personal History: 
                                         Yes/ No                       Duration 
Smoker 
Tobacco chewer 
Alcoholic 
Diet 
Dinner time 
Bed time 
 
 
 
 ix 
 
Examination Findings 
Indirect Laryngoscopy findings: 
GRBAS 
Pitch:  Increased /decreased/ diplophonia 
Reflux Symptom Index   Questionnaire           0-no problem 
                                                                              5-severe problem 
    Symptoms   
 0 
 
   1 
 
  2 
 
  3 
 
  4 
 
  5 
 1 
 
Hoarseness or problem with  voice       
 2 
 
Clearing your throat       
 3  
   
Throat mucus or post nasal drip       
 4 
 
Difficulty in swallowing solids, liquids or 
pills 
      
 5 
 
Coughing after you have eaten or after 
lying  down 
      
 6 
 
Breathing difficulties  or  choking  
episodes 
      
    
7 
Troublesome or annoying  cough       
 8 
 
Sensation or lump in your throat       
 9 
 
Heartburn or stomach  acid  coming up       
                                               Total Score= 
 x 
 
Endoscopic Findings: 
 
Diagnosis- 
Reflux Finding Score 
 
1) Subglottic oedema     
           
     absent              0 
      present              2 
2) Ventricular obliteration 
                    
    partial               2 
    complete               4 
3) Vocal fold oedema                    
                          
    mild                1 
    moderate                2 
    severe                3 
    polypoidal                4 
       4) Posterior commissure hypertrophy 
 
    mild                 1 
    moderate                 2 
    severe                 3 
    obstructing                 4 
  
 
 
 
 xi 
 
5) Granuloma/ Granulation tissue 
                           
    absent                 0 
    present                 2 
6) Erythema/ Hyperaemia 
                       
  arytenoids only                2 
   diffuse                4 
7) Diffuse laryngeal oedema 
                         
   mild              1 
   moderate              2 
   severe              3 
   obstructing              4 
8) Thick endolaryngeal mucus 
                         
   absent             0 
   present             2 
 
Total Score = 
 
DOA:                                                DOS:                                             DOD: 
Operative findings: 
Biopsy report: 
 
Giemsa report: 
PCR report: 
 
 xii 
 
 
                                    EXCEL DATA SHEET 
 
 
 
 
 
serial nohosp no age  Sex          :Male -1,Female-2occupationlevel of voice useHoarseness : yes -1, no-2duration belching : yes -1,no-2durationThroat pain : yes -1, no-2durationforeign b dy sensation throat  : yes -1,no -2durationswallowi g difficulty : yes -1, no- 2durationbreathing difficulty : yes -1, no- 2durat onvoice abus  : yes -1, no- 2durationcough : yes -1, no- 2durationthroat clearing : yes -1, no- 2durationeck swelli g : yes -1, no- 2durationsmokerdurati nt bacco chewerduration
1 728575f 60 1 subinspector 3 1 2 years 2 2 1 3 years 2 2 1 30 years 2 1 3 years 2 1 4 years 1 34 years
2 747426F 62 1 forestry department 3 1 1 1/2 years 1 2months 1 13 months2 1 2months 2 2 2 1 1 month 2 1 20 years, 10-12 /day2
3 709641f 34 1 engineer 4 1 1 1/2 years 1 4 years 2 2 2 2 1 2 years 2 1 4 years 2 1 15 years,1-2 /week2
4 749680f 28 2 housewife4 4 1 3 months 1 6 years 1 3 months 1 3 months 1 3 months 1 3 months 2 1 7 years 1 7 years 2 2 2
5 385653f 43 1 police 2 1 10 years 1 6 years 2 2 2 2 1 15 years 2 1 10 years 2 1 5 years,3-4/month2
6 653164f 63 1 Manual labourer4 1 1 year 2 2 1 1 month 2 2 2 1 1 month 1 1 month 2 1 35 years,24beedi/day2
7 280607d 77 1 Manual labourer4 1 3 months 2 2 2 2 2 2 2 2 2 1 40 years,2-3beedi/day2
8 736370c 47 1 Professor 2 1 5 years 2 2 1 3 years 2 2 1 5 years 2 1 10 years 2 1 25 years,1/day2
9 683367f 67 1 Farmer 2 1 3 months 2 2 2 2 2 2 1 2 months 1 3 months2 1 35 years,4 beedi/day2
10 743431f 46 1 Carpenter 2 1 1 year 1 7 years 2 1 2 years 2 2 1 10 years 2 1 2 years 2 2 2
11 776178f 49 1 Manual labourer3 1 4 years 2 2 2 2 2 1 15 years 2 2 2 1 15 years,5 cigg/day1 1 1 2 years,1-2 times/day
12 066870f 75 1 Driver 4 1 2 month 2 2 2 2 1 2 years 2 1 2 years 2 2 1 35 years,24 beedi/day2
13 760049f 44 1 Shop keeper 3 1 2 years 2 2 2 2 2 1 10 years 2 1 15 years 2 2 2
14 183647f 48 1 Architect 4 1 1 month 2 2 2 2 2 2 2 2 2 1 30 years.2 packets/day2
15 798019f 33 1 Manual labourer3 1 1 month 2 2 2 2 2 2 2 2 2 1 15 years,2/day2
16 799999f 41 1 Serviceman 4 1 8 months 2 2 2 2 2 1 10 years 2 1 5 years 2 2 1 15 years,5-6 times/day
17 799819f 59 1 Govt employee2 1 6 months 2 2 2 2 2 1 10 years 2 2 2 1 42 years,10-12 cigg/day2
18 805861f 52 1 Lawyer 2 1 2 1/2 months 1 2 years 2 2 2 2 1 30 years 2 1 2 months2 2 1 3 years,4 times/day
19 749337f 60 2 Housewife4 4 1 11 months 2 2 2 2 2 2 2 2 2 2 2
20 779521f 35 1 Student 3 1 1 year 1 7 months 2 1 7 months 2 2 2 2 2 2 2 2
21 773541f 28 1 Manual labourer2 1 2 months 2 2 1 2 months 2 2 1 2 months 2 1 2 months2 1 2 years.5-6/day2
22 796345F 56 1 Printing work 4 1 2 years 2 2 2 2 2 2 2 2 2 2 2
23 812613f 56 1 Manual labourer3 1 7 months 2 2 2 2 2 1 30 years 2 1 7 years 2 1 26 years,10 beedi/day.stopped for 10 years1 3 y ars,stopped
24 769023f 44 1 Teacher 2 1 2 months 2 2 2 2 2 1 18 years 2 1 10 years 2 1 22 years.8 cigg /day2
25 809798f 44 2 Nurse 3 1 2 years 1 5 years 2 2 2 2 2 2 2 2 2 2
26 817582F 50 1 engineer 2 2 1 3 years 2 1 2 1/2 years 2 2 1 2 years 2 2 2 2 2
27 811353f 31 1 Business man 3 1 4 months 2 2 2 2 2 1 3 years 2 1 4 months2 2 2
28 429092f 54 1 Labourer 4 1 3 months 2 2 2 2 2 2 2 2 2 1 25 years,25 beedis/day2
29 694622f 45 1 Business man 3 1 2 years 1 12 years 2 2 2 2 2 2 1 2 years 2 1 4 years,1-2/day1 20 ears
30 808335 69 2 Housewife 4 1 2 years 2 2 2 2 2 2 2 2 2 2 2
31 268290f 20 2 Housewife 4 1 2 years 2 2 2 2 2 2 2 2 2 2 2
32 694753f 43 1 Porter 2 1 20 years 1 15 years 2 1 10 years 2 2 1 20 years 2 1 10 years 2 2 1 20 years.6-8 times/day
33 759528f 47 1 Business man 3 1 7 months 2 2 1 3 months 2 1 3 months 2 1 3 months 1 3 months2 1 30 years.10 cigg/day1 30 years,2 times /day
34 814149f 40 1 Farmer 3 1 2 months 2 1 2 months 1 1 month 2 2 2 2 2 2 2 1 6 years
35 814541f 56 1 Operator in steel authority2 1 2 years 2 2 2 2 2 1 18 years 2 2 2 2 1 2 1/2 years,3 times/day
36 821627f 37 1 Serviceman 3 2 1 7 years 2 1 10 years 2 2 1 6 months 2 2 2 1 2 years.2/day2
37 820175f 44 1 Farmer 3 1 2 months 1 10 years 2 1 2 years 2 2 1 2 years 2 1 5 months2 1 25 years,6 /day1 20 ears,3 times/day
38 026218f 76 1 Manual labourer3 1 25 days 2 2 2 2 2 2 2 1 10 years 2 1 20 years, 50 beedis /day2
39 723713f 52 1 Construction worker2 1 7 months 1 10 years 2 1 3 months 2 2 1 30 years 2 1 7 months2 1 10 years,1 packet/day2
40 766527d 70 1 Teacher 2 1 6 months 2 2 2 2 2 1 30 years 2 2 2 1 55 years,2-3 packet/day2
41 778435d 49 1 engineer 3 1 3 months 1 3 years 2 2 2 2 1 20 years 2 1 2 years 2 1 20 years,1 cigg/day2
42 833322f 41 1 Contractor 2 1 3 months 2 2 2 2 2 1 8 years 2 1 1 month 2 1 3 years,3 cigg/day2
43 829140f 39 1 Business man 3 1 4 months 1 4 months 2 2 2 2 2 2 2 2 2 1 1/week
44 829877f 33 1 Business man 3 1 5 months 2 2 2 2 2 2 2 2 2 2 2
45 146671d 37 1 construction worker2 1 4 months 1 20 years 2 2 2 2 1 10 years 2 2 2 2 2
46 211200c 71 1 Manual labourer3 1 12 years 2 2 2 2 2 2 2 2 2 2 2
47 836034f 59 1 Carpenter 3 1 10 years 2 2 2 2 2 1 40 years 2 1 2 years 2 1 34 years/48/day1
48 829848f 50 1 LIC Agent 3 1 1 1/2 years 2 2 1 6 months 2 2 2 2 1 6 months2 2 2
49 368891D 46 1 Policeman 2 1 2 months 2 2 2 2 2 1 23 years 2 1 1 year 2 2 2
50 833912f 64 1 Manual labourer3 1 8 months 2 2 1 1 week 2 2 2 2 1 10 years 2 1 35 years,1 packet/day2
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alcoholicdurationDM : yes -1, no- 2duratioHTN : yes -1, no- 2durationTB : yes -1, no- 2durationPPI : yes -1, no- 2Antibiotics : yes -1, no- 2dinner timebed timeGRBAS      RSI      RFS FINDINGS Diagnosis   Biopsy  Giemsa 1- positive, 2-negativePCR 1- positive, 2- negative
1 stopped 15 yrs back,1-2 pints /month2 1 4 year 2 2 2 9.00 pm10.30 pmG1RIB2 10 4 Proliferative growth along the entire length of right vocal cord extending upto anterior commissure anteriorly and vocal process posteriorly,ventricle superiorly and undersurface of cord anteriorly.carcinoma gl ttism derately differentiated squamous cell carci oma.2 2
2 2 2 2 2 2 9.00 pm10.30 pmGIRIBI 10 6 Proliferative growth involving  petiole of epiglottis, both vocal cords, extending upto anterior commissure anteriorly and involving subglottis circumferentially.transglottic carcinomamoderately d fferentiated squamous cell carcinoma.2 2
1 15 years,1-2 peg/day2 2 2 2 2 10.30 pm11.00pmG2R2B0 12 11 Large broad  based polyp arising from middle one tird of left true cord.voc l cord polypbenign vocal cord polyp2 2
2 2 2 2 2 2 8.00 pm9.00 pmG1RIB1 20 11 Huge pedunculated polyp arising from anterior one third of right vocal cordright vocal cord polypu cer t o  and polypoidal granulation tissue2 2
1 5 years,2-4 pegs /yeaR2 2 2 2 2 no fixed timeim diately after foodG2R2BO 9 8 Haemorrhagic polyp at junction of anterior one third and posterior two thirds of left vocal cord.left v cal cord polypbenign vocal cord p lyp2 2
1 15 years,1 peg/week2 2 2 2 2 11.00 pmimmediately after foodG1R1B1 8 2 Papillomatous lesion involving right vocal cord,false cord and anterior one third of left vocal cord.papi loma larynxflorid papillary epithelial proliferation with mild dysplasia2 2
2 2 1 5 years 2 2 2 8.00 pm9.00 pmG3R1B0 5 6 Exophytic growth involving anterior one third of right vocal cord extending to anterior and lateral wall of subglottis.Anterior commissure free.carcinoma g ottism der tely differ ntiated squamous cell carcinoma.2 2
1 5 years,occassionally 20ml/week2 2 2 2 2 8.00 pm10.30 pmG2R2B0 12 7 Polyp at  the junction of anterior one third and posterior two thirds of left vocal cordl ft vocal cord polypbenign vocal cord polyp2 2
2 2 1 1 month 2 2 2 8.00 pm8.30 pmG3R2B0 6 5 Haemorrhagic  polyp at  the anterior one third  of right vocal cordright vocal cord polypbenign vocal cord polyp2 2
2 2 2 2 2 2 11.00 pm11.30 pmG3R2B0 11 5 Polyp in the medial surface of right vocal cord at the junction of anterior one third and posterior two thirdsright vocal cord p lypbenign vocal cord polyp2 2
2 1 5 years 2 2 2 2 10.30 pm12.00 amG2R1B1 3 3 Sessile haemorrhagic polyp at the junction of anterior one third and posterior two thirds of right vocal cordright vocal cord olypbenign vocal cord p lyp2 2
2 2 2 2 2 2 10.00 pm10.30 pmG3R2B1 6 6 Irregular keratotic plaque seen involving middle two thirds of  both vocal cords.Bilateral cords are mobile.m lignancy glottismoderate dysplasia2 2
2 2 2 2 2 2 10.30 pm11.00pmG2R2B0 6 1 Pedunculated  haemorrhagic polyp in the anterior one third of left vocal cord.l ft vocal cord  haemorrhagic polypbenign vocal cord polyp2 2
1 2 years,2 pegs/week,stopped.2 2 2 2 2 8.30 pm1.30amG2R1B0 3 4 Whitish patch over anterior aspect of right vocal cordchronic laryngitissubepithelial chronic infl mmation2 2
1 5 years. 2 pegs durng occasions1 1 year 2 2 2 2 9.00 pm11.00pmG3R3B0 6 9 Small whitish plaque over anterior one third of bilateral vocal cords.Voca  cord KeratosisEpithelial hyperplasia with mild to m derate ubepithelial inflammation.2 2
2 2 2 2 2 2 9.30 pm11.30 pmG3R3B1 5 3 Polyp at  the junction of anterior one third and posterior two thirds of left vocal cordl ft vocal cord ha m rrhagic polypbenign vocal cord polyp2 2
2 2 2 2 2 2 11.00pm2.30 amG2R2B0 4 3 keratotic patch over middle one third of right vocal cord involving superior and medial surfaceright vocal cor  keratosisepith lial hyperplasia 2 2
2 2 2 2 2 2 9.30 pm10.30 pmG3R3B0 11 6 Pedunculated  polyp at junction of the anterior one third and posterior two thirds of left vocal cord.l ft vocal cord polypleft v cal cord polyp with mild o moderate dyskerat sis and fibrinoid degeneration2 2
2 1 6 years 2 2 2 2 11.00pm11.30 pmG2R1B0 5 3 Pale polyp at the junction of anterior one third and posterior two thirds of right vocal cordright vocal cord polypbenign vocal c d polyp2 2
2 2 2 2 2 2 9.00 pm11.00 pmG3R2S1 8 3 Polyp at  the junction of anterior one third and posterior two thirds of right vocal cordright vocal cord polypbenign vocal cord polyp2 2
1 2 years,2 pegs on occasions.2 2 2 2 2 8.00 pm11.00pmG2R2B0 8 3  Polyp at  the junction of anterior one third and posterior two thirds of right vocal cordright vocal c rd polypbenign vocal cord polyp2 2
2 2 1 1 month 2 2 2 8.00 pm11.30 pmG3R3B1 8 6 Slough covered proliferative lesion involving entire length of right vocal cordmalignancy glottiswell d fferentiated squamous cell carcinoma2 2
1 3 years,stopped1 8 y ars 1 7 years 2 2 2 12.00am12.30 amG3R3B2 8 3 Proliferative lesion over anterior one third of left vocal cord extending to the anterior commissure and extending to right vocal cord with involvement of subglottis bilaterallycarcinoma glottisw ll to moderately differ n iated squamous cell carcinoma2 2
2 2 1 10 years 2 2 2 11.00pm11.30 pmG2R2B0 5 7 Broad based polyp  over anterior one third of left vocal cord.left vocal cord polypb nign fibroepithelial polyp2 2
2 2 2 2 2 2 10.30 pm11.00 pmG3R3B1 7 6 polyp at the junction of anterior one third and posterior two thirds of right vocal cordright vocal cord polypbenign v cal cord polyp2 2
2 2 2 2 2 2 10.00 pm10.10 pmG0R0B0 7 6 Small sessile polyp  seen on medial one third of left vocal cordleft vocal cord polypb ig vocal cord polyp2 2
2 2 2 2 2 2 9.30 pm11.00 pmG3R3B0 7 1 Haemorrhagic polyp at the anterior one third of right vocal cordright vocal cord polypbenign vocal cord polyp2 2
2 2 1 5 years 2 2 2 10.00pm10.30 pmG3R3B2 7 0 Exophytic growth involving entire length of right vocal cord,abutting left vocal cord,right venticle and reaching to right subglottis.maligna cy glottiswell to mod rately di ferentiated squamous cell carcinoma2 2
2 1 2 years 2 2 2 2 9.30 pm11.30 pmG3R3B0 10 7 polyp at the junction of anterior one third and posterior two thirds of right vocal cordright vocal cord polypbenign v cal cord polyp2 2
2 2 2 2 2 2 8.30 pm10.00pmG2R2B1 6 5 Papillomatous lesion involving   anterior two third of left vocal cord and involving anterior commissure,extending to subglottisvoca  cord papil omaSquamous papilloma2 2
2 2 2 2 2 2 8.30pm 10.00 pmG3R2B2 6 13 Irregular granular growth extending along entire length  of bilateral vocal cords,anterior commissure and interarytenoid region. granuloma larynepithelial hyperplasia  w th dense infammation and occasio al granuloma2 2
2 2 1 3 years 2 2 2 11.00 pm11.30 pmG2R2B1                                                                                              9 10 Pedunculated multilobed polyp arising from anterior one third of right vocal cordright vocal corbenign vocal cord polyp2 2
1 30 years,3 pegs/day2 2 2 2 2 9.00 pm11.00 pmG2R2B1 12 0 Proliferative lesioninvolving bilateral arytenoids,bilateral aryepiglottic folds ,epiglottis  and bilateral true and false cords.Carcin ma supraglottiswell to moderately differentiated squamous cell arcinoma2 2
2 2 2 2 2 2 10.30 pm11.00 pmG3R3B0 9 5 Polyp in the  anterior one third of left vocal cord  l ft vocal cord polypbenign vocal cord polyp2 2
1 40 years,5 pegs/day1 6 years 1 15 years 2 2 2 9.00 pm9.30 pmG3R3B1 8 6 Papillomatous broad based pedunculated lesion arising from anterior one third of right vocal cord  involving anterior commissure and extending to subglottispapilloma larynxBenign papillom  larynx2 2
2 2 2 2 2 2 10.30 pm12.00amG1R1B0 8 8 Reddish granular mass involving whole of right ventricular bandright  ventricular ba d   polypbe ign haemorrhagic polyp2 2
1 15 years,70 ml/day2 2 2 2 2 9.00 pm10.00pmG3R2B0 16 5 Small polyp in the anterior one third of left vocal vordleft vocal cord polypb nign  vocal cord polyp2 2
2 2 1 10 years 2 2 2 8.00pm 10.00pmG2R1B2 8 7 Exophytic growth involving  right vocal cord from posterior one third to anterior commissurecarcinoma g ottiswell to moderately differentiated squamous cell c rcinoma2 2
2 2 2 2 2 2 10.30pm11.00pmG3R2B0 12 9 Small haemorrhagic polyp over the medial surface of anterior one third of right vocal cordright vocal cord polypbenign vocal cord polyp2 2
1 50 years,1 quarter/day1 week 1 1 week 2 2 2 8.00pm 9.00pmG3R2B3 7 10 Proliferative growth involving  entire length of left  vocal cords, left venticle and infrahyoid epiglottis.malignancy gl tt smoderately d ffer tiated squamous cell carcinoma.2 2
2 2 2 2 2 2 10.00 pm11.30 pmG3R2B0 15 9 Multilobulated polypoidal lesion on the anterior one third of left vocal cordleft vocal c r  polypbenign polyp wit  ulceration and regenerative hanges2 2
1 10 years,once in 2 months2 2 2 2 2 10.00pm11.00 pmG3R3B0 9 5 Proliferative lesion involving anterior two thirds of right vocal cordmaligna cy glottiswell d fferent ated squamous cell carcinoma2 2
2 2 2 2 2 2 12.30am1.00 amG3R3B0 8 6 Haemorrhagic polyp at the junction of anterior one third and posterior two thirds of left vocal cord.left v cal cord polypleft v cal cord polyp with mild dyspl sia2 2
2 2 2 2 2 2 8.00pm 8.30pmG2R2B1 6 5 Haemorrhagic polyp at the junction of anterior one third and posterior two thirds of right vocal cord.right vocal cord polypbenign vocal cord polyp2 2
2 2 2 2 2 2 7.00pm 9.30pmG2R2B0 8 8 Polyp in the anterior one third of left vocal cordl ft vocal c rd polypbenign vocal  cord po yp2 2
2 2 2 2 2 2 8.30 pm10.00pmG3R3B3 7 5 Multiple warty papillomatous lesion involving right AEF,both false cord and true cordsrecurrent aryngeal papillomatosislaryngeal papi lo atosis wit  focal low gr d dysplasia2 2
2 2 2 2 2 2 10.00pm11.30pmG3R3B0 9 4 Haemorrhagic polyp in the anterior one third of left vocal cordleft v cal cord polypbenign left vocal cord polyp2 2
2 1 10 years 2 2 2 2 9.30 pm11.00 pmG2R2BO 8 10 Ulceroproliferative lesion involving entire length of left vocal cord up to anterior commissure and just crossing over to right vocal cordCarcinoma insitu  glottisfocal se ere dysplasia-su gestiv  of Ca in situ2 2
2 2 2 2 2 2 10.00 pm1.00 amG2R2B0 7 4 Whitish keratotic lesion in posterior one third of left vocal cordVocal ord Keratosiepithelial hyperplasia with focal mild dysplasia2 2
2 2 2 2 2 2 10.00pm12.00 amG3R1B3 11 3 Ulceroproliferative lesion involving entire length of  right vocal cord extending upto subglottis.Right hemilarynx fixedmalignancy glottiswell to moderately differentiated squamous cell carcinoma2 2
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51 835998f 29 1 Farmer 3 1 4 years 2 2 1 3 years 2 2 2 2 2 2 1 10/day,stopped 4years back1 4 times/day
52 824796f 53 1 Private company employee4 1 6months 2 2 2 2 2 2 2 2 2 2 2
53 831693f 36 2 Housewife 4 1 2 years 2 2 1 2 years 2 2 2 2 1 2 years 2 2 2
54 838135f 40 1 Tea Seller 3 1 3months 2 2 2 2 2 1 15years 2 1 5 months2 1 5years,4beedis/day1 10 years,3 times/day
55 821761f 36 1 LIC Agent 3 1 7 years 1 5years 2 2 2 2 1 10 years 2 1 6 years 2 1 16 years,6/day2
56 836696f 27 1 Business 3 1 6months 2 2 2 2 2 2 2 2 2 2 2
57 829439f 74 1 Farmer 4 1 4 years 2 1 2 months 1 6 months 2 2 2 2 2 2 1 5 years,2-3 beedis/day1 15 years,5 times/day
58 825798f 58 1 Manual labourer4 1 8 months 2 2 2 2 2 2 2 1 8 months2 1 40 years,30 beedi/day1 20 years,6times/day
59 834860f 35 1 Farmer 4 1 3 months 2 2 2 2 2 2 2 1 3 months2 1 10 years,5 cig/day2
60 680381f 45 2 Housewife 4 1 3 years 1 3 years 2 2 2 2 1 10 years 2 2 2 2 2
61 018056c 29 1 Medical representative2 1 7 years 2 1 1 1/2 years2 2 2 1 7 years 2 1 5 years 2 2 2
62 815049F 51 1 Shop keeper 4 1 1 year 2 2 2 2 2 1 10 years 2 2 2 1 25 years,4 beedi/day2
63 840880f 65 1 Farmer 4 1 2 1/2 years 2 2 2 2 1 2 years 2 2 2 2 1 50 years,15/day2
64 838576f 34 1 Teacher 2 1 3months 2 2 2 2 2 1 6 years 2 1 3 months2 2 2
65 848778f 43 1 Businessman 3 1 3 years 2 2 2 2 2 2 2 1 3 years 2 2 2
66 849456f 40 1 Private company employee3 1 15 ars 2 2 1 9 years 2 2 1 10 years 2 1 4 years 2 1 27 years,4 cigg/day1 20 ye rs,once in a day
67 860006f 27 2 Housewife 4 1 5years 2 2 2 2 1 6 months 2 2 2 2 2 2
68 858811f 57 1 Businessman 3 1 2 years 2 2 2 2 2 1 14 years 1 1 month 1 1 month 2 1 10 years,5 cig/day2
69 862617f 57 1 Warden 3 1 2 years 2 1 2 months 2 1 1 month 2 1 28 years 1 1 month 1 2 months2 1 20 years,10 cigg/day2
70 857037f 48 1 Business man 3 1 2 years 2 2 2 2 2 1 10 years 2 2 2 1 5 years,5 beedi/day2
71 862376f 50 1 Carpenter 3 1 9 months 2 2 2 2 2 2 2 2 2 1 20 years,20 beedi/day2
72 867230f 48 1 Farmer 4 1 4 years 2 2 1 3 months 2 2 2 2 1 4 months2 1 12 years,6 beedi/day2
73 617616f 53 1 engineer 3 1 1 year 2 2 2 2 2 1 20 years 2 2 2 2 2
74 809516f 57 1 Housewife 4 1 25 years 1 3 years 2 1 25 years 2 1 10 years 2 2 1 3 years 2 2 2
75 871662f 65 1 Retired lecturer2 1 4 months 2 2 2 2 2 1 30 years 2 2 2 2 2
76 860621f 65 1 Pastor 2 1 6 months 2 1 1 month 2 2 2 1 40 years 2 2 2 1 10 years,6 beedi/day2
77 876935f 60 1 Tea shopkeeper4 1 2 years 2 2 1 2 months 2 1 4 months 1 2 months 1 7 months 1 4 months2 2 1 10 years,4-5 times/day
78 870933f 25 1 engineer 3 1 3 months 2 2 1 2 months 2 2 1 5 years 2 1 2 months2 1 3 years,1 cigg/day1 3 ye rs
79 882577f 44 1 Fish seller 3 1 3 months 2 2 2 2 2 1 30 years 2 1 3 months2 1 15 years,4 beedi/day1 15 years,3 times/day
80 844618f 45 1 Business 4 2 2 1 2 months 1 2 months 1 1 month 1 1 week 2 1 1 month 1 2 months2 1 20 years,10 beedi/day2
81 879915f 39 1 Vegetable seller3 1 6 months 1 5 years 2 2 2 2 1 15 years 2 1 6 months2 2 2
82 878057f 61 1 Teacher 2 1 2 months 2 2 2 2 2 1 40 years 2 2 2 1 40 years,15 beedi/day1 40 years,2-3 times/day
83 866104d 48 2 Drama actress 2 1 1 year 1 2 years 2 2 2 1 8 months 1 4 years 2 1 2 years 2 2 2
84 882615f 76 1 Shop keeper 4 1 6months 2 2 1 2 1/2 months2 1 4 months 2 2 1 10 years 2 1 40 years,1 packet beedi/day2
85 881624f 35 1 Driver 4 1 7 years 2 2 2 2 2 2 2 2 2 1 35 years,10 beedi/day2
86 886394f 40 2 Contractor 2 1 4 months 2 2 2 2 2 1 10 years 2 2 2 2 1 5 years,4 times/day
87 380069c 56 1 Postman 2 1 4 years 1 5 years 2 2 2 2 1 6 years 2 1 5 years 2 1 5 years,6-7 cigg/day2
88 886917f 74 1 Waiter 3 1 3 months 2 2 1 1 month 2 2 1 25 years 1 5 years 2 2 1 50 years,15/day2
89 891027f 36 1 Civil Engineer 3 1 3 months 1 10 years 2 1 3 months 2 2 1 10 years 1 3 months 1 3 months2 1 `18 years,40/day1 20 years,2-3 times/day
90 666518d 35 1 Serviceman 3 1 2 months 2 2 1 2 months 2 2 1 15 years 2 1 2 months2 2 2
91 891094f 47 1 Teacher 2 1 2 months 1 3 years 2 2 2 2 1 24 years 1 10 years 1 10 years 2 1 20 years,10 beedi/dayoccasional
92 884718f 29 1 Works in Press3 1 4 months 1 6 years 2 1 4 months 2 2 1 10 years 2 1 4 months2 1 3 years,15 beedi/day2
93 893999f 29 1 Teacher 2 1 1 month 2 2 2 2 2 1 5 years 2 1 2 months2 2 2
94 391234f 43 1 Actor 2 1 1 year 2 2 2 2 1 3 months 1 10 years 2 2 2 1 20 years,15-20/day1 20 ye rs,5-6 times/day
95 897419f 50 2 Housewife 4 1 2 months 2 2 2 1 6 months 2 2 2 2 2 2 2
96 819670F 31 1 engineer 3 1 8 months 1 3 years 2 1 8 months 2 2 1 3 years 1 1 year 1 8 months2 1 3 years,5-6/day2
97 865371f 36 1 Farmer 3 1 6months 1 6 years 2 2 2 2 1 10 years 1 4 years 1 6 months2 1 10 years,4-5 cigg/day2
98 767830f 36 1 Shop keeper 3 1 4 years 1 10 years 2 1 4 years 2 2 1 12 years 2 1 12 years 2 1 15 years,stopped2
99 813304d 49 1 Driver 3 1 3 months 2 2 1 2 2 1 10 years 2 1 1o years 2 2 2
## 005964g 52 1 Serviceman 4 1 3 months 2 2 1 3 months 2 2 1 25 years 2 1 3 months2 2 2
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2 2 2 2 2 2 9.00pm 10.00pmG2R2B0 11 6 Whitish proliferative lesion seen at the junction of anterior 2/3rd and posterior 1/3rd of left vocal cordleft vocal cord polypb nig  polypoidal lesion with focal ulceration and bacterial colonisation,secondary inflammation and epithelial hyperplasia2 2
1 10 years,90ml /week.2 1 2 years 2 2 2 10.00 pm11.00pmG2R1B0 6 6 Haemorrhagic polyp in left vocal cord at the junction of anterior one third and posterrior two thirdsleft v cal cord polypLeft v cal cord haemorrhagic polyp2 2
2 2 2 2 2 2 8.30pm 9.00pmG3R3B0 11 6 Large pedunculated  haemorrhagic  polyp arising from the superior surface of anterior one third of left true cord.left vocalcord polypbenign vocal cord polyp2 2
1 occasional,4 years2 2 2 2 2 8.30pm 10.30pmG2R2B1 8 6 Haemorrhagic polyp at the junction of anterior one third and posterior two thirds of left vocal cord.left v cal cord haemorrhagic polypbenign vocal cord polyp2 2
2 1 2years 2 2 2 2 10.30pm11.00pmG2R2B0 14 5 Broad based polyp  over anterior one third of rightvocal cord.Right vocal cord polypoc l co d lyp with focal mild dyskeratosis2 2
2 2 2 2 2 2 9.30pm 11.00pmG2R1B0 6 3 Polypoidal lesion involving the left vocal cord2 2
2 2 2 2 2 2 9.30pm 10.00pmG2R2B1 10 3 Exophytic growth involving anterior two thirds of left vocal cord,false cord involving free margin of epiglottis and anterior commissure going into subglottis. t ansglottic carcinomawell to modera ely differentiated squamous cell ca cinoma2 2
1 15years,60ml/day1 1month 2 2 2 2 8.30pm 10.00pmG3R2B2 8 6 Verrucous lesion seen on the middle and  anterior one third of left vocal cord,extending into subglottis going on to the anterior commissure and anterior part of right vocal cord.Fl rid epthelial hyperplasia with dense inflammation.2 2
1 10 years,30 ml/day2 2 2 2 2 9.30pm 10.30pmG2R2B0 6 7 Broad based papillomatous lesion over the anterior one third of left vocal cord.left vocal cord po ypbenign vocal cord polyp2 2
2 2 1 3 years 2 2 2 10.30pm11.30pmG2R2B1 8 3 Sessile polyp at the middle one third of right vocal cordright vocal cord  polypbenign polyp ight vocal c rd.2 2
2 2 2 2 2 2 8.00pm 11.30pmG3R2B1 9 8 Pedunculated polyp at the junction of anterior one third and posterior two third of right vocal cordRight vocal cord polypbenign vocal cord polyp2 2
1 10 years,60 ml/week1 4 years 1 4 years 2 2 2 8.00pm 9.00pmG3R2B1 6 3 Broad  based papillomatous lesion attached to anterior one third of right vocal cordright vocal cord polypv cal c rd polyp with  mild dyske atosis2 2
2 2 2 2 2 2 9.00pm 10.00pmG3R1B3 7 1 Proliferative lesion involving left aryepiglottic folds,left arytenoid extending to left false cord,ventricle anf left true cordcarcinoma supraglottiscarcinoma insitu with foci suspicious of invasive squamous c ll c rcinoma.2 2
2 2 2 2 2 2 9.00 pm10.00pmG2R1B0 7 6 Haemorrhagic polyp at anterior one third of right vocal cordright vocal cord polypbenign v cal cord polyp2 2
2 2 2 2 2 2 12.00am1.00amG2R2B0 8 3 Broad based haemorrhagic polyp on the anterior one third of left vocal cordleft vocal cord polypbenign  vocal cord polyp2 2
2 2 2 2 2 2 11.00pm12.00amG2R1B1 12 6 Large polypoidal papillomatous growth involving anterior half of left vocal cord,anterior commissure and anterior one third of right vocal cord.right vocal cord polypBenign vocal cord polyp.2 2
2 2 2 2 2 2 11.00pm12.00 amG3R1B3 6 4 Multiple papillomatous lesions involving the true cords,ventricle,false cords and over the arytenoids.Larynge l PapillomatosisL ryngeal papil omatosis with koilocytes2 2
2 2 1 2 years 2 2 2 10.00pm11.30pmG2R2B0 11 6 Mucosa covered bulge over the left aryepiglottic fold,false vocal cord,ventricle.Ulceration over left true vocal cord and in the anterior and lateral wall of subglottis circumferentiallyCa cinoma supraglottism d ately differ ntiated squamous cell carcinoma.2 2
2 2 2 2 2 2 9.00pm 10.00pmG3R2B1 15 8Exophytic growth involving laryngeal surface of epiglottis,Left AEF,left false cord,left true cord anf left pyriform sinus carcinoma glottisSuggestive of squamous cell carcinoma.2 2
2 2 2 2 2 2 10.00pm11.00pmG2R1B0 5 5 Polyp seen on the anterior one third of left vocal cordLeft voc l cord polypB nign vocal cord polyp2 2
2 2 2 2 2 2 10.30pm11.30 pmG3R2B0 6 7 Ulceroproliferative growth involving entire length of right vocal cord,extending to the anterior commissure and infiltrating the subglottiscarcinoma glottism derately differentiat d squamous cell carcinoma.2 2
2 2 2 2 2 2 11.00pm11.20 pmG3R3B1 11 8 Proliferative growth involving entire length of left ventricular band,left ventricle and superior surface of left vocal cord .Carcinoma supraglottisModerately o poorly  differentiated squamous cell carcinoma.2 2
2 1 6 months1 6 months2 2 2 9.00pm 10.30 pmG2R2B1                                                                                              7 4 Broad based haemorrhagic polyp at the junction of anterior one third and posterior two thirds of left vocal cord.Left vocal cord polypBenign vocal cord polyp.2 2
2 2 2 2 2 2 9.00pm 10.00 pmG2R1B0 15 8 broad based polyp in the anterior onethird of right vocal cord arising from the superior surfaceright vocal cord polypbenig  vocal cord polyp2 2
2 2 2 2 2 2 9.00pm 9.30 pmG2R1B0 5 2 Exophytic growth involving entire length of right vocal cord upto anterior commissure and right ventricular bandcarcinoma g ottism derately differentiated squamous cell carcinoma.2 2
2 2 2 2 2 2 8.00 pm9.00pmG3R2B1 9 12 Irregular surfaced lesion over the anterior one third of left vocal cord.Smooth mucosa covered bulge involving left false cord.Left ventricle obliteratedt ansglottic carcinomaP orly differe iated squamous cell carcinoma.2 2
2 2 1 5 years 2 2 2 10.00pm10.30 pmG3R1B2 12 8 Proliferative growth involving right true cord,false cord,aryepiglottic fold,anterior commissure extending to left false cord and anterior onr third of true cord extending to subglottistransglottic carcinomawell d ffe entiated squamous cell c rcinoma2 2
1 3 years,60 ml /week2 2 2 2 2 9.00 pm10.00 pmG2R2B1 10 4 Haemorrhagic sessile polyp at the junction of anterior one third and posterior two thirds of right vocal  cord.right vocal cord olypBenign vocal cord p lyp.2 2
2 2 2 2 2 2 9.00 pm 11.00 pmG3R2B3 9 7 Extensive whitish keratotic growth involving anterior two third of bilateral vocal cord,across anterior commissure,going to anterior subglottisVocal cord KeratosisKeratosis it  candid colonisation.2 2
2 2 2 2 2 2 9.30 pm10.30 pmG1R1B0 14 4 Exophytic growth involving right aryepiglottic fold,right arytenoid,right false cord.Carcinoma supraglottismoderately differentiated squamous c ll carcinoma.2 2
2 2 2 2 2 2 11.00 pm12.00amG2R2B0 10 3 Bilateral haemorrhagic polyp at the junction of anterior one third and posterior two thirds of bilateral vocal cordBilateral vo al cord polypBenign e it lial polyp2 2
2 2 2 2 2 2 9.30pm 10.30 pmG3R3B1 10 8 Proliferative growth involving petiole of epiglottis,left ventricular band,left venticle,superior surface of left vocal cord,anterior commissure and superior aspect of anterior one third of right vocal cordCarcinoma supraglottismoderately diff rentiated squamous cell carcinoma.2 2
2 2 2 2 2 2 10.00pm12.00 amG3R2B0 14 7 Proliferative growth with keratotis involving anterior one third of right vocal cord,anterior commissure and going to medial subglottisCarcinoma  glottismoderately differentiated squamous cell carcinoma.2 2
2 1 10 years 2 2 2 2 10.00pm10.30 PMG3R2B0 15 4 Irregular growth over the entire length of right vocal cord extending to  subglottis and false cord and ventricleCarcin ma glottiswell differentia ed squamous cell carcinoma2 2
2 2 2 2 2 2 10.00pm11.30 pmG2R2B0 9 6 Broad based polyp in the posterior one third of left vocal cord with keratosis along the entire length of true vocal cords.vocal cord poly  with keratosiSP s.No evidence of malignancy.2 2
2 2 1 5 years 2 2 2 9.00pm 10.30 pmG3R2B2 8 5 Irregular lesion over the right vocal cord with keratotic surfce going onto the anterior surface,slough covered lesion extending to subglottis over the right side.Laryngeal tuberculosisNec otising granulomatous inflammation.2 2
2 2 1 2 years 2 2 2 10.00pm10.30pmG2R1B0 10 9 Haemorrhagic polyp at the junction of anterior one third and posterior two thirds of right vocal cord.Right vocal cord polypBenign polyp,right vocal cord.2 2
2 2 2 2 2 2 9.30pm 10.30pmG3R2B1 12 2 Proliferative lesion involving right ventricle,entire length of right true cord,subglottis on the right side.Edematous left ventricletransglottic carci omawell to moderately diff rentiated squamous cell carcinoma2 2
1 20 years,60 ml/week.2 2 2 2 2 9.30 pm11.00pmG2R1B0 15 8 Pedunculated polyp at the anterior one third of right vocal cord.Right vocal cord polypBenign polyp 2 2
2 2 2 2 2 2 9.00 pm10.00pmG2R1B0 8 1 Broad based polyp on the superior surface of anterior one third of right vocal cordright vocal cord polypBenign vocal cord polyp2 2
2 1 3 years 2 2 2 2 10.00pm11.00pmG1R1B0 10 8 Ulceroproliferative growth involving right false cord,arytenoid extending to the right pyriform sinus and righy aryepiglottic fold.Right hemilarynx fixed.Carcinoma supraglottismoderately differenti ted squamous cell carci oma.2 2
2 2 2 2 2 2 9.30 pm11.00pmG2R1B1 14 9 Small broad based polyp in the anterior one third of right vocal cord.Right vocal cord polypBenign voc l cord  polyp2 2
2 2 2 2 2 2 9.00pm 11.00pmG3R2B1 8 8 Large pedunculated polyp arising from the medial surface of  anterior one third of left vocal cord.Left vocal c rd polypBenign vocal c rd polyp2 2
1 60-100ml/week1 2 y ars 2 2 2 2 10.00pm11.00pmG3R3B2 11 5 Ulceroproliferative growth involving entire length of left vocal cord, false  cord,ventricle extending to the left side of subglottis and anterior commissure.Left arytenoid edematoustransglottic carcinomamoderately differentiat d squamous cell carcinoma.2 2
2 2 2 2 2 2 10.00pm12.00 amG2R1B0 10 3 Ulceroproliferative growth arising from laryngeal surface of epiglottis,left pharyngoepiglottic fold and lateral wall of left pyriform sinusCarcinoma supraglottismoder tely differentiated squamous cell carcinoma.2 2
2 2 2 2 2 2 10.00pm10.30pmG2R2B1 15 7 Large pedunculated polyp at the junction of anterior one third and posterior two thirds of left vocal cord.left vocal cord olypbenign vocal cord polyp2 2
1 60 ml/wk,stopped2 2 2 2 2 10.00pm10.30pmG2R1B1 17 8 Sessile broad based polyp at the junction of anterior one third of right vocal cordright vocal cord polypbenign vocal cord polyp2 2
2 2 2 2 2 2 10.00pm10.30 pmG2R2B2 14 8 Polyps at the junction of anterior one third and posterior two thirds of bilateral vocal cord.Bilateral vocal cord p lypBenign vocal cord polyp2 2
2 2 1 3 years 2 2 2 9.30 pm10.30 pmG2R1B1 7 4 Reddish polypoidal lesion in the anterior one third of right vocal cordRight vocal cord polypBenign vocal cord polyp2 2
2 2 2 2 2 2 9.30 pm10.30 pmG3R3B1 11 3 polyp at the junction of anterior one third and posterior two thirds of right vocal cordright vocal cord polypBenign v cal cord polyp2 2
